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Executive Summary 
This report is the final output from the independent evaluation of the innovative Rotherham Social 
Prescribing Pilot undertaken by the Centre for Regional Economic and Social Research (CRESR) 
at Sheffield Hallam University. It provides a detailed assessment of the social and economic 
impact of the pilot from the perspective of key stakeholders. 
What is social prescribing? 
Social prescribing provides a way of linking patients' in primary care and their carers with non-
medical sources of support within the community. It is tailor-made for voluntary and community 
sector (VCS)-led interventions and can result in:  
 better social and clinical outcomes for people with long-term conditions (LTCs) and their carers  
 more cost-efficient and effective use of NHS and social care resources 
 a wider, more diverse and responsive local provider base. 
Social Prescribing in Rotherham 
The Rotherham Social Prescribing Pilot was delivered by Voluntary Action Rotherham (VAR) on 
behalf of NHS Rotherham CCG. It was funded for two years from April 2012 to March 2014 as part 
of a wider GP-led Integrated Case Management Pilot and aimed to increase the capacity of GP 
practices to meet the non-clinical needs of their patients with long-term conditions (LTCs). The 
pilot received around £1m as part of a programme to provide 'additional investment in the 
community' and began receiving referrals from September 2012 onwards. Over the course of the 
Pilot:  
 24 voluntary and community organisations (VCOs) received grants with a total value of just 
over £600,000 to deliver a menu of 31  separate social prescribing services 
 1,607 patients were referred to the service, of whom 1,118 were referred on to funded VCS 
services. In parallel, more than 200 referrals were made to non-funded VCS provision and 
more than 300 referrals were made to statutory services 
 the five most common types of funded services referred to were information and advice, 
community activity, physical activities, befriending and enabling.  
The Pilot was one of the largest of its kind, covering the whole of the borough. It has since been 
re-commissioned for a further year and forms part of Rotherham's multi-agency proposal to the 
Better Care Fund. Furthermore, in March 2014 the Pilot received the 'Excellence in Individual 
Participation Commissioner' award at NHS England’s Excellence in Participation Awards 2014. In 
addition, it has been influential in the development of NHS policy at a national level, including as 
part of the NHS' 'Improving general practice - a call to action' initiative, which aims to support 
action with the potential to transform services in local communities and support general practice to 
improve outcomes and tackle inequalities. 
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Impact on the demand for hospital care 
Using patient-level Hospital Episode Statistics (HES) the evaluation mapped over time Social 
Prescribing patients' use of hospital resources, including unplanned care, comparing the number of 
inpatient admissions, Accident and Emergency attendances and outpatient appointments before 
and after referral. 
The analysis identified a clear overall trend that points to reductions in patients' use of hospital 
resources after they had been referred to Social Prescribing:1 
 Inpatient admissions reduced by as much as 21 per cent 
 Accident and Emergency attendances reduced by as much as 20 per cent 
 Outpatient appointments reduced by as much as 21 per cent 
 Greater reductions in inpatient admissions and Accident and Emergency attendances were 
identified for patients who were referred on to funded VCS services. 
Social impact 
Patients who were referred to the Social Prescribing Pilot experienced improvements in their well-
being and made progress towards better self-management of their condition. Analysis of well-
being outcome data showed that, after 3-4 months, 83 per cent of these patients had experienced 
positive change in at least one outcome area. Importantly, when the results were broken down by 
category they showed that progress was made against each outcome measure and that a majority 
of low-scoring patients made progress. 
These findings were reinforced by case study interviews with a number of Social Prescribing 
patients who experienced a range of well-being outcomes, including improved mental and physical 
health, feeling less lonely and socially isolated, becoming more independent, and accessing a 
wider range of welfare benefit entitlements. 
Economic and social benefits 
A number of positive economic benefits to commissioners linked to the Social Prescribing Pilot 
have been estimated: 
 estimated total NHS cost reductions by the end of the pilot of £552,000: a return on 
investment of 50 pence for each pound (£1) invested 
 potential NHS cost reductions of £415,000 in the first year post-referral when the service is 
running at full capacity 
 if these benefits identified are fully sustained over a longer period 
- the costs of delivering the service for a year would be recouped after between 18 and 24 
months 
- the five year cost reductions for commissioners for each full year of service delivery could 
be as high as £1.9 million: a return on investment of £3.38 for each pound (£1) invested 
- even if the benefits are sustained but drop-off at a rate of 33 per cent each year they 
could lead to total cost reductions of £807,000: a return on investment of £1.41 for each 
pound (£1) invested. 
                                               
1
 At this stage these figures are estimates based on only partial data on a sub-set of Social Prescribing beneficiaries. It 
will be possible to refine these estimates in future years once a longer time period has elapsed. 
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The value of a range of social benefits associated with Social Prescribing were also estimated 
using financial proxies and techniques associated with social return on investment (SROI) analysis: 
 the estimated value of patients' well-being benefits was between £819,000 and £920,000 by 
the end of the pilot 
 the potential value of well-being benefits is between £660,000 and £742,000 in the first year 
post-referral when the service is running at full capacity 
 the estimated annual value of volunteering to the pilot was between £81,000 and £148,000: 
an additional £0.16 - £0.26 (16 - 26 pence) for each pound (£1) invested in the pilot by the 
CCG 
 the estimated value of additional welfare benefits claimed was £350,000 over the course of 
the pilot 
 the estimated value of additional funding accessed by funded VCS services providers was at 
least £200,000 over the course of the course of the pilot. 
Conclusion 
The findings from the evaluation of the Rotherham Social Prescribing Pilot demonstrate that 
economic and social benefits, or outcomes, have been created for three main stakeholder groups: 
 patients with LTCs and their carers have experienced improved mental health, become 
more independent, less isolated, more physically active, and begun engaging with and 
participating in their local community. They have also been able to access a range of welfare 
benefits that they were previously unaware of. Social Prescribing services have provided these 
patients and carers with an important first step to engaging with community based services and 
wider statutory provision that they would not otherwise have been aware of. 
 the local public sector, in particular health bodies, have benefitted because Social 
Prescribing patients' use of hospital resources - the number of inpatient stays, Accident and 
Emergency attendances and outpatients appointments - reduced by up to fifth in the 12 months 
following their referral to Social Prescribing. This translates into potential positive financial 
returns to commissioners in a relatively short period following the initial referral2.  
In addition, the local public sector has experienced broader outcomes. For example, patients 
accessing the service are generally more satisfied with the support they received and feel 
better supported to manage their condition. Furthermore, there is emerging evidence that non-
health services, in particular social and residential care, benefit from similar reductions in 
resource utilisation and service delivery costs.3. 
 the local voluntary and community sector (VCS) has benefitted from a catalytic investment 
in community level service provision, which has enabled small organisations without a track 
record in health service provision to access NHS funding for the first time. Some providers 
have been able to 'match' their Social Prescribing with income from other sources, to enhance 
their provision and improve the overall sustainability of their organisation.  
Overall, the pilot has demonstrated the potential for community based provision to make a 
positive and cost-effective contribution to local strategic health and well-being priorities, and 
provides a strong foundation for these types of providers to continue making a positive 
contribution through commissioned services in the future. 
 
                                               
2
 At this stage these findings carry an important caveat: there are too few patients analysed and too little time has 
elapsed to produce findings that are statistically significant. In 12 months' time it will be possible to produce more 
statistically robust evidence, as a larger number of patients will have been tracked over a longer period. 
 
3
 Detailed analysis of social care data would be needed to properly quantify the extent of these reductions 
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 1 1. Introduction 
This report is the final output from the independent evaluation of the innovative 
Rotherham Social Prescribing Pilot.  The Pilot was delivered by Voluntary Action 
Rotherham (VAR) in partnership with more than 20 local voluntary and community 
organisations (VCOs). It was commissioned by NHS Rotherham and funded from 
April 2012 to March 2014 as part of a wider GP-led Integrated Case Management 
Pilot with the aim of increasing the capacity of GP practices to meet the non-clinical 
needs of their patients with long-term conditions (LTCs), including support for their 
carers.  At its core, the Rotherham Social Prescribing Pilot funded the provision of a 
voluntary and community sector (VCS) liaison service which: 
 enabled patients and their carers to access support from local VCS 
organisations, with a view to improving health and well-being, and their ability 
to self-manage conditions 
 for the first time, contributed a VCS perspective to the assessment of needs 
and care planning for patients referred to multi-disciplinary Integrated Case 
Management Teams (ICMTs) 
 built capacity within the VCS, enabling the development of new community-
based services with the potential to improve health and well-being and promote 
self-help and independence. 
The Pilot received around £1m of funding from NHS Rotherham as part of a 
programme to provide 'additional recurrent investment in the community' during the 
transition from the Primary Care Trust (PCT) to the Clinical Commissioning Group 
(CCG).  
1.1. About the evaluation 
The evaluation was undertaken by the Centre for Regional Economic and Social 
Research (CRESR) at Sheffield Hallam University. It had a number of aims: 
 assess the impact of the pilot for its key stakeholders 
 assess whether the aims and outcomes of the project had been achieved 
 provide analysis of costs-benefits and return on investment, including assessing 
the cost savings and efficiencies to the NHS  
 assess the effectiveness of the service delivery model 
 establish a business case for future funding. 
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An interim evaluation report, 4  published in December 2013, identified emerging 
lessons from the evaluation and provided a series of recommendations for 
stakeholders and commissioners going forward. 
1.2. About this report 
This final evaluation report provides an assessment of the social and economic 
impact of the pilot between September 2012 and March 2014. It draws on a variety 
of data sources: 
 analysis of client management and monitoring data collected by VAR 
 analysis of hospital episodes data for a cohort of beneficiaries of the Pilot 
 in-depth interviews with public sector stakeholders, project staff, and voluntary 
and community organisations (VCOs) delivering services 
 case studies involving service beneficiaries 
 an online survey of funded VCS providers. 
The report is divided into the following chapters: 
 Chapter 2 provides an introduction to social prescribing  
 Chapter 3 provides an overview of the activities and outputs of the pilot 
 Chapter 4 provides analysis of the impact of the pilot on the demand for hospital 
care 
 Chapter 5 provides analysis of the social impact of the pilot 
 Chapter 6 provides analysis of the economic and social cost-benefits of the pilot 
 Chapter 7 is the conclusion and outlines the business case for continuing Social 
Prescribing in Rotherham 
 Appendix 1 provides five detailed case studies of services provided through the 
Pilot 
 Appendix 2 provides a summary of all services funded through the Pilot. 
 
                                               
4
 http://www.shu.ac.uk/research/cresr/sites/shu.ac.uk/files/rotherham-social-prescribing-final.pdf  
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2 2. What is social prescribing? 
This chapter provides an introduction to social prescribing and discusses the context 
in which the Rotherham Pilot was developed. It begins by discussing the main policy 
developments of the past few years before giving an overview of the ideas that 
underpin social prescribing and the different models that have been developed. It 
concludes by outlining the innovative social prescribing model enacted in Rotherham, 
including the structures and processes that enabled it to function effectively. 
2.1. Policy Context 
The Pilot emerged at an important time for the NHS at a local level. The 
announcement that GPs will take over the commissioning role previously undertaken 
by Primary Care Trusts (PCTs) was made in the 2010 White Paper, 'Equity and 
Excellence: Liberating the NHS.' It was part of wider Government moves to create a 
clinically driven commissioning system that is more sensitive to the needs of patients. 
The 2010 White Paper became law under the Health and Social Care Act 2012 in 
March 2012. 
PCTs have been replaced by Clinical Commissioning Groups (CCGs) which operate 
by commissioning healthcare services including: 
 elective hospital care 
 rehabilitation care 
 urgent and emergency care 
 most community health services 
 mental health and learning disability services. 
CCGs were developed to give GPs and other clinicians more influence over 
commissioning decisions for their patients. They are responsible for coordinating 
emergency and urgent care services within their boundaries, which tend to be 
coterminous with local authorities. They involve healthcare professionals working in 
partnership with patients, local communities and statutory agencies to meet the 
health needs of local people. All NHS GP practices must belong to a CCG. 
In addition to these developments, the Marmot Review (2010) has been particularly 
influential in shaping health policy at all levels. The Review found that people in the 
poorest neighbourhoods die sooner and spend more of their lives with a disability.  
As a result, people who live in deprived communities, or who are marginalised in 
terms of access to health and well-being information, support and services in other 
ways, are more likely to: 
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 present late with long-term conditions (LTCs) 
 require emergency or unscheduled care 
 experience greater co-morbidity 
 be less likely to attend routine GP appointments for reviews of their condition 
and attend specialist clinics and outpatient appointments. 
These factors combine to make these patients more complex to manage clinically, 
and increase their risk of experiencing complications associated with poor 
management of their condition.  They also result in higher than average use of 
emergency care, unscheduled care and complex clinical interventions and are, 
ultimately, a greater cost burden to the State.  
2.2. An introduction to social prescribing 
Solutions for improving the health and well-being of people from marginalised and 
disadvantaged groups that place greater emphasis on preventative interventions 
have become increasingly common in public policy. This is reflected in the public 
health White Paper, ‘Healthy Lives, Healthy People’, which states: 
“...it is not better treatment, but prevention – both primary and secondary... 
which is likely to deliver greater overall increases in healthy life expectancy.”  
One such solution, often referred to as social prescribing, focuses on secondary 
prevention by commissioning services that will prevent worsening health for people 
with existing LTCs, and reduce costly interventions in specialist care.  Social 
prescribing links patients in primary care and their carers with non-medical sources 
of support within the community.  It is tailor-made for VCS-led interventions and can 
result in: 
 better social and clinical outcomes for people with LTCs and their carers 
 more cost efficient and effective use of NHS and social care resources 
 a wider, more diverse and responsive local provider base. 
As such, social prescribing provides GPs with a non-medical option that can operate 
alongside existing treatments and enable a more holistic approach to improving 
health and well-being.  
2.3. Models of social prescribing 
Social prescribing interventions can vary enormously, but often include: 
 condition management programmes that provide support in areas such as 
education; managing pain and fatigue; healthy eating; exercise; emotional 
support; support for self-care; understanding care pathways; and self-help 
groups 
 health and well-being support  through activities such as interactive craft groups; 
interactive music sessions for people with dementia; community gardening 
projects; men’s peer support groups; healthy cooking clubs; walking groups; 
specialist yoga; chair-based exercise; and assistive technology support 
 support to access or maintain employment, education or wider community 
participation; including one-to-one support; group work; social activities; training, 
 Centre for Regional Economic and Social Research | 5 
apprenticeships; support to access community facilities; and community 
transport 
 emotional and practical support through intervention such as peer mentoring; 
stroke communication groups; welfare rights and benefits advice; signposting; 
befriending; dementia cafes; gym buddies; support with aids and adaptations; 
handyperson services; and language support for people with learning disabilities 
or from BME communities 
 specific support for carers, including respite care; short breaks; therapeutic 
activities; emotional and practical support, including peer support groups; and 
advice, information and guidance 
 volunteering opportunities, such as peer mentors, befrienders, and community 
car drivers. 
Social prescribing delivery models typically involve dedicated workers whose role is 
to liaise with providers and enable referred patients and carers to access the service 
prescribed. This might include assistance with overcoming practical barriers, moral 
support or confidence-building activities. Social prescribing can therefore be 
appropriate in a variety of circumstances: 
 when a medical intervention is unlikely to work and a social intervention could 
be more appropriate 
 when the patient appears to need alternative ways to channel their energies  
 when the patient or carer could benefit from more integration or involvement 
with their local community 
 when empowerment or self-help might enable a patient or carer to resolve their 
own difficulties. 
2.4. Evidence in support of social prescribing 
There is growing evidence that social prescribing works: evidence from similar pilot 
projects undertaken in the UK suggests that real changes can be identified after 18-
24 months. Outcomes include:  
 improved health and quality of life 
 increased patient satisfaction 
 fewer primary care consultations 
 reductions in the number of hospital admissions, visits to Accident and 
Emergency, and outpatient attendances 
 a decrease in the use of wider hospital resources. 
Measuring progress against these and other linked outcomes is a key test of the 
Rotherham Social Prescribing Pilot's success, in particular the ability of local VCS 
providers to meet the needs of patients with LTCs and their carers, and become a 
more integral part of mainstream health and social care provision in the borough in 
the future. 
2.5. The Rotherham Social Prescribing model 
The Rotherham Social Prescribing Pilot was commissioned by NHS Rotherham as 
part of a GP-led Integrated Case Management Pilot. It aimed to increase the 
capacity of GPs to meet the non-clinical needs of patients with complex long-term 
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conditions (LTCs) who are the most intensive users of primary care resources. 5 
Specific support for the carers of case-managed patients was also provided. The 
Pilot received funding of £1.1 million between April 2012 and March 2014 to provide 
a voluntary and community sector (VCS) liaison service for the whole borough which: 
 enabled patients and their carers to access support from local VCS 
organisations 
 contributed a VCS perspective to the assessment of needs and care planning 
for patients referred to multi-disciplinary Integrated Case Management Teams 
(ICMTs) 
 enabled the development of new community-based services to fill gaps in 
provision, and funded additional capacity within existing VCS to meet the 
increase in demand created by Social Prescribing. 
44 per cent of the funding covered the core cost of developing and running the Pilot, 
with the remaining 56 per cent providing a grant funding pot for a 'menu' of VCS 
activities. The key components of the service are described below. Diagrammatic 
representation of the model is provided in Figure 2.1 (overleaf).  
The Pilot became fully operational in September 2012. A core team consisting of a 
Project Manager and five Voluntary and Community Sector Advisors (VCSAs) was 
employed by VAR. The Project Manager's role was to oversee the day-to-day 
running of the Pilot, including management of the grant programme, and acting as a 
liaison between VCS providers and wider NHS structures. The VCSA role provided 
the link between the Pilot and the multidisciplinary ICMTs. They received referrals 
from GP practices of eligible patients and carers and made an assessment of their 
support needs before referring them on to appropriate VCS services. The 
assessment typically took place during a home visit where the VCSA would talk 
through the patient's needs and discuss the options available to them through social 
prescribing. VSCAs also formed part of the ICMT and attended meetings when 
Social Prescribing patients were being discussed.  
The Pilot covered the whole of the borough of Rotherham.  As such it was one of the 
largest of its kind, as the majority of social prescribing activity in the UK has had a 
much smaller geographic focus. It has since been re-commissioned for a further year 
and forms part of Rotherham's multi-agency proposal to the Better Care Fund. 
The Pilot has also received national recognition: in March 2014 it received the 
'Excellence in Individual Participation Commissioner' award at NHS England’s 
Excellence in Participation Awards 2014. In addition, it has been influential in the 
development of NHS policy at a national level, including as part of the NHS 
'Improving general practice - a call to action' initiative, which aims to support action 
with the potential to transform services in local communities and stimulate debate 
about how general practice can be supported to improve outcomes and tackle 
inequalities. 
 
                                               
5
 A risk stratification tool is used to identify the five per cent most intensive users of services: these patients and 
their carers are eligible for case management and can access social prescribing. 
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Figure 2.1: The Rotherham Social Prescribing Model 
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3 3. Social prescribing activities 
and outputs 
This chapter provides an overview of the activities and outputs of the Rotherham 
Social Prescribing Pilot drawing on the comprehensive programme and client 
monitoring data collected by the VAR project team. It begins with an overview of the 
outputs and activities delivered between April 2012 and March 2014 before 
discussing in more detail the types of voluntary and community sector services 
provided and the range of referrals in to and out of the service. 
3.1. The inception and development process 
Although the Social Prescribing Pilot was commissioned in April 2012 the first 
referrals to the Pilot were not made until August 2012 and the majority of VCS 
services did not commence until January 2013 or later. Prior to this, time was spent 
getting the Pilot up and running. This included staff recruitment; developing 
relationships with GP practices and Case Management Teams, including raising 
awareness of the Pilot and the benefits of social prescribing for patients and carers; 
developing programme management systems, including a commissioning framework 
and grant monitoring systems; working to understand need and gaps in existing 
provision; and identifying and developing partnerships with the range of potential 
VCS providers across the borough. 
Prior to April 2012 VAR, its VCS partners and NHS Rotherham had worked closely to 
establish the business case for Social Prescribing and develop a model of provision 
that could be embedded in the Case Management Pilot.  
3.2. Commissioning from voluntary and community sector providers 
The pilot commissioned services from local VCS organisations in two phases. The 
first phase was in autumn 2012 through which ten voluntary and community 
organisations (VCOs) were commissioned to deliver social prescribing services. 
Some of these services began receiving patients towards the end of 2012 
(November/December) but the majority did not commence until January 2013 
onwards. The second phase was in spring 2013 through which a further 13 VCOs 
were commissioned to deliver services. These services began receiving patients 
from June 2013 onwards. Overall, 24 VCOs received grants to deliver a menu of 31 
separate social prescribing services. The value of these grants was £610,598: this 
included direct grants to the value of £506,266 and a 'floating fund' of £104,331, 
available for a range of non-grant funded services to be 'spot purchased'. Overall, 
funding for services commissioned from the VCS accounted for 56 per cent of the 
total project budget.  
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An overview of services funded through the pilot, including the number of referrals to 
each service throughout the Pilot is provided in Table 3.1. A more detailed summary 
is available in Appendix 2. 
Table 3.1: Summary of funded social prescribing services in Rotherham 
Service provider Type of service or activity 
No of referrals 
2012/13 2013/14 
Active Independence 
Peer advocacy with volunteering 
opportunities 
10 63 
Active Regen 
Group activity/mobility sessions; 
Senior peer mentoring - 'Active Friends' 
buddy scheme 
- 89 
Age UK Rotherham 
Advice and Information 
Reablement service 
Befriending service 
104 373 
Alzheimers Society 
Dementia Support Worker Service 
Dementia Volunteer Befriending service 
30 117 
British Red Cross 
Volunteer-led befriending and enabling 
service 
- 78 
Crossroads Care 
Respite service 
Complimentary therapies 
Carers peer support group 
14 172 
Elmet Archaeological 
Services Ltd 
Drop-in reminiscence group - 18 
High Street Centre Activity Co-ordinator 3 46 
Kimberworth Park 
Community Partnership 
Home visits and referral to community 
activities 
12 152 
Montgomery Hall Activity Co-ordinator  11 34 
Rotherham Community 
Transport 
Volunteer driver scheme and improved 
booking and scheduling service 
55 155 
Rotherham Ethnic Social 
Care Organisation 
Group activity programmes for BME carers - 18 
Rotherham Titans 
Community Foundation 
Home visits from Rotherham Titans first 
team players 
Group activities at Clifton Lane Sports 
Ground 
- 88 
Rotherham United 
Community Sports Trust 
Home Exercise visits 
New York Stadium activity sessions 
Community based activity sessions 
36 167 
Royal Voluntary Service 
Volunteer-led good neighbours befriending 
and enabling scheme 
- 43 
Satori Counselling 
One-to-one therapeutic counselling and 
additional group work sessions 
- 20 
Self Management UK Caring with Confidence course  - 21 
Sense Sensory art & craft group sessions  - 69 
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South Yorkshire Centre for 
Inclusive Living 
One-to-one Support Worker  
Facilitated 'afternoon tea' sessions 
29 234 
Sure Health Community based Tai Chi classes - 57 
Tassibee 
One-to-one peer advocacy and enabling 
service for BME women 
5 13 
Unity Centre Group activity sessions for Asian men  2 16 
Universal Embrace 
Complimentary Therapy and social group 
sessions 
31 136 
You Ask We Respond  
Advocacy 
Befriending and enabling 
Group Activities 
Sitting Service 
4 51 
3.3. Social prescribing referrals 
The section provides an overview of social prescribing referral patterns.6 It covers 
both referrals-in to the Pilot (i.e. by GPs and ICMTs to VCSAs) and referrals-out (i.e. 
by VCSAs to funded VCS services and wider provision). 
Referrals-in to social prescribing 
Between September 2012 and March 2014 the Pilot actively engaged with 29 (out of 
36) GP practices in Rotherham to receive referrals-in from ICMTs as part of the Case 
Management Pilot. Overall, 1,607 referrals-in were received compared to an initial 
target of 940. Within these referrals a number of patterns were evident. 
Age 
The majority of patients referred to the pilot were elderly: 
 87 per cent were aged 60 or over 
 75 per cent were aged 70 or over 
 47 per cent were aged 80 or over 
 10 per cent were aged 90 or over 
Gender 
Females (61 per cent) were more likely to be referred to the pilot than males (39 per 
cent).  
Ethnicity 
A large majority of referred patients were from a White ethnic background (91 per 
cent) with fewer than five per cent from other ethnic backgrounds.7 
                                               
6
 Note that although the headline figures presented are for the whole 2 years of the Pilot detailed analysis of 
referrals is based data collected by the Pilot up to the end of January 2014: 1,329 of the total 1,607 referrals-in to 
the service. 
7
 6 per cent of SPS clients' ethnicity was not stated 
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GP practice 
The volume of referrals-in to the Social Prescribing Pilot varied considerably by GP 
practice. Four practices referred more than 100 patients, five referred between 50 
and 100 patients, 12 referred between 25 and 49 patients and ten referred less than 
25 patients (including three that referred less than 10). 
Table 3.2: Summary of GP referrals to the Rotherham Social Prescribing Pilot 
 No of Patients Referred to SPS 
 100 plus 50-100 25-49 10-24 
Less 
than 10 
Dinnington Group Practice      
Morthen Road Surgery      
Swallownest Health Centre      
Clifton Lane Corner Surgery      
Parkgate Medical Centre      
Broom Lane Medical Centre      
Kiveton Primary Care Centre      
Market Surgery      
Blyth Road Medical Centre      
St Ann's Medical Centre      
Kilnhurst Surgery (Magna Group)      
Village Surgery Thurcroft      
York Road Surgery      
Shakespeare Road Surgery      
Crown Street Surgery      
Rawmarsh Health Centre      
Stag Medical Centre      
High Street Surgery      
Manorfield Surgery      
Wickersley Health Centre      
Greasbrough Medical Centre      
Maltby Service Centre      
Thorpe Hesley Surgery      
Greenside Surgery      
Queens Medical Centre      
Broom Valley Road Surgery      
Thrybergh Medical Centre      
Woodstock Bower Group Practice      
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Brinsworth Medical Centre      
Treeton Medical Centre      
Surgery of Light      
Referrals-out  
Funded VCS services 
Over the course of the Pilot there were 2,584 onward referrals of 1,118 patients 
(many had more than one onward referral) to funded VCS services. Figure 3.1 
provides an overview of referrals-out to the VCS by service type. 
Although some types of service received particularly high numbers of referrals - 
information and advice and community activity for example - what is particularly 
striking is the broad range of services that were accessed through Social Prescribing. 
In addition, the high demand for services such as befriending and community 
transport highlights the importance of services that aim to reduce dependence and 
social isolation. These types of intervention might be seen as a 'first step' for patients 
aiming to access a wider range of community provision more independently in future. 
Figure 3.1: Overview of referrals out to funded VCS services by service type 
(Sept 2012-Jan 2013) 
 
Multiple referrals to funded provision were also a notable feature of the Pilot. More 
than half of all (53 per cent) patients referred-out to grant funded provision through 
the Pilot were referred to more than one service. Of these, 26 per cent received two 
referrals-out, 15 per cent received three, 7 per cent received four, and 4 per cent 
received five or more. 
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Wider VCS provision 
In addition to referrals to VCS services in direct receipt of funding through the Social 
Prescribing Pilot, 15 per cent of patients were referred to the wider pool of VCS 
provision available in the borough. This included other services available from 
existing Social Prescribing providers such as Age UK (for example gardening and 
cleaning services) as well as services available from other VCS organisations such 
as Headway and Stayput.  
This highlights how the Pilot served as a gateway to a wider pool of VCS provision, 
and the added value this brings to commissioners and GPs, who would have 
otherwise been unable to link patients with these types of services. 
Statutory provision 
A further, unexpected function of the Pilot was to make referrals-out to statutory 
sector services; 22 per cent of patients were referred to additional statutory provision. 
The most common of these were RMBC OT Assessment and Intermediate Care and 
the Fire Brigade for fire safety checks, but referrals were also made to NHS services 
such as Breathing Space and community-level services such as falls prevention 
classes and community alarms. Although it cannot be said for certain that these 
referrals would not have occurred eventually through other means, in many cases it 
has ensured that the referral happened sooner rather than later. 
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 4 4. Impact on the demand for 
hospital care 
This chapter presents analysis exploring the impact of the Rotherham Social 
Prescribing Pilot on demand for hospital-based health interventions. It draws on 
patient-level Hospital Episode Statistics (HES) provided by the NHS to map over 
time the use of hospital resources by patients referred to the Social Prescribing 
Service since the Pilot's inception. Three types of hospital episode are considered: 
inpatient admissions; accident and emergency attendances; and outpatient 
appointments. 
4.1. Methodology 
Data sources and variables 
The analysis presented in this chapter is based on psuedonymised patient-level 
hospital episode data for Social Prescribing patients provided by the NHS Data 
Management and Integration Centre (DMIC). Data linkage was made using the NHS 
numbers of Social Prescribing patients provided by Voluntary Action Rotherham. All 
inpatient stays, accident and emergency presentations, and outpatient appointments 
between April 2011 and December 2013 were included in the data. An overview of 
all variables included in the data set is provided in Table 4.1. 
Table 4.1: Overview of HES variables provided by DMIC 
General  
Variables 
Admissions  
Variables 
A and E 
Variables 
Outpatient 
Variables 
GP practice code 
Destination at 
Discharge 
Outcome  Outcome 
Admission or 
attendance type  
Primary diagnosis on 
admission 
A&E diagnosis 
Emergency 
assessment flag 
Month of admission 
or attendance 
Primary procedure on 
admission 
Hospital Reference 
Group code 
 
Year of admission or 
attendance 
Length of stay in days 
from admission to 
discharge 
  
Age group at 
admission or 
attendance 
Hospital Reference 
Group code  
  
Patient gender 
   
Treatment  
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Following exploratory analysis of all the data provided a series of outcome variables 
were created to provide the basis of the headline analysis presented in this report. 
These are outlined in Table 4.2. 
Table 4.2: Overview of outcome variables 
Inpatient  
admissions 
A and E 
attendances 
Outpatient  
appointments 
No of inpatient admissions in 
the 6 months prior to referral 
No of A and E attendances 
in the 6 months prior to 
referral 
No of outpatient 
appointments in the 6 
months prior to referral 
No of inpatient admissions in 
the 12 months prior to 
referral 
No of A and E attendances 
in the 12 months prior to 
referral 
No of outpatient 
appointments in the 12 
months prior to referral 
No of inpatient admissions in 
the 6 months following 
referral 
No of A and E attendances 
in the 6 months following 
referral 
No of outpatient 
appointments in the 6 
months following referral 
No of inpatient admissions in 
the 12 months following 
referral 
No of A and E attendances 
in the 12 months following 
referral 
No of outpatient 
appointments in the 12 
months following referral 
Change in no of admissions 
in the 6 months following 
referral 
Change in no of A and E 
attendances in the 6 months 
following referral 
Change in no of outpatient 
appointments in the 6 
months following referral 
Change in no of admissions 
in the 12 months following 
referral 
Change in no of A and E 
attendances in the 12 
months following referral 
Change in no of outpatient 
appointments in the 12 
months following referral 
Sampling 
Analysis focussed on patients that were referred to the Social Prescribing Pilot 
during its first ten months of operation (September 2012-June 2013). For these 
patients sufficient time had elapsed post referral to begin observing changes in their 
utilisation of hospital services. Analysis was undertaken of two cohorts of patients 
referred to the Pilot:  
 the 12 month cohort included all patients for whom 12 months post-referral 
data was available i.e. all patients referred between September and December 
2012 (n=108)  
 the six month cohort included all patients for whom six months post-referral 
data was available i.e. all patients referred between September 2012 and June 
2013 (n=451). 
Analysis 
Analysis was undertaken on both samples to measure changes in the use of hospital 
resources by Social Prescribing patients. As part of this analysis the changes 
experienced by a sub-group of patients who had been referred to funded VCS Social 
Prescribing services were also considered. For the 12 month cohort the number of 
each type of episode was compared for the 12 month periods before and after 
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referral to Social Prescribing. For the six month cohort the six month periods before 
and after referral were compared. Additional descriptive analysis was undertaken on 
both samples to explore the proportion of Social Prescribing patients who 
demonstrated an overall reduction in each type of service use. 
An overview of the numbers in each sample is provided in Table 4.3. 
Table 4.3: Overview of analysis groups and cohorts 
 
12 
months 
6 
months 
All patients referred to Social Prescribing 108 451 
Social Prescribing patients referred to a grant 
funded provider 
42 248 
An overview of the analysis undertaken is presented in tables 4.4-4.7 and the main 
findings are discussed in the section that follows. 
Table 4.4: Change in per-patient utilisation of hospital resources - 12 month 
cohort 
 
All patients referred to 
Social Prescribing 
Patients referred to a grant 
funded VCS provider 
12m 
before 
12m 
after 
Change 
12m 
before 
12m 
after 
Change 
No of  
inpatient 
admissions 
1.46 1.17 -0.30 1.45 1.10 -0.36 
No of A&E  
attendances 
1.94 1.56 -0.39 2.19 1.67 -0.52 
No of 
outpatient 
appointments 
1.70 1.30 -0.36 1.90 1.36 -0.55 
Table 4.5: Change in per-patient utilisation of hospital resources - six month 
cohort 
 
All patients referred to 
Social Prescribing 
Patients referred to a grant 
funded VCS provider 
6m 
before 
6m 
after 
Change 
6m 
before 
6m 
after 
Change 
No of  
inpatient 
admissions 
0.59 0.51 -0.08 0.58 0.44 -0.13 
No of A&E  
attendances 
0.76 0.67 -0.09 0.75 0.63 -0.12 
No of 
outpatient 
appointments 
0.74 0.63 -0.11 0.72 0.69 -0.03 
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Table 4.6: Proportion of patients demonstrating a reduction in utilisation of 
hospital resources - 12 month cohort 
 
All patients referred to 
Social Prescribing 
Patients referred to a grant 
funded VCS provider 
n reduced % reduced n reduced % reduced 
Inpatient 
admissions 
43 40 20 48 
A&E 
attendances 
41 38 18 43 
Outpatient 
appointments 
51 47 23 55 
Table 4.7: Proportion of patients demonstrating a reduction in utilisation of 
hospital resources - six month cohort 
 
All patients referred to 
Social Prescribing 
Patients referred to a grant 
funded VCS provider 
n reduced % reduced n reduced % reduced 
Inpatient 
admissions 
107 24 66 27 
A&E 
attendances 
113 25 66 27 
Outpatient 
appointments 
141 31 74 30 
4.2. Summary of findings 
Inpatients admissions 
The 12 month cohort saw an overall reduction of 21 per cent in the number of 
inpatient admissions in the 12 month period following referral to Social Prescribing: 
patients referred to funded VCS services saw a greater reduction (0.36 per patient) 
than the full cohort (0.26 per patient) - a difference of 0.10 admissions per patient. 
Overall, 40 per cent of all referred patients saw a reduction in inpatient admissions 
but the proportion was greater for patients who had been referred to funded VCS 
services (48 per cent). 
The pattern in the six month cohort was very similar. There was a small overall 
reduction (of 14 per cent) in the number of inpatient admissions in the six month 
period following referral to Social Prescribing with those patients who had been 
referred to funded VCS services seeing a greater reduction (0.13 per patient) than 
the full cohort (0.08) per patient) - a difference of 0.05 admissions per patient. 
Overall, 27 per cent of patients referred to a funded VCS service saw a reduction in 
inpatient admissions compared to 24 per cent of the full cohort. 
Accident and Emergency attendances 
Similar to inpatient admissions, the 12 month cohort saw an overall reduction in the 
number of Accident and Emergency attendances of 20 per cent in the 12 month 
period following referral to Social Prescribing: patients referred to a funded VCS 
service saw a greater reduction (0.52 per patient) than the full cohort (0.39 per 
patient) - a difference of 0.13 attendances per patient. Overall, 38 per cent of all 
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referred patients saw a reduction in Accident and Emergency attendances but the 
proportion was greater for patients who had been referred to funded VCS services 
(43 per cent). 
Again, the pattern in the 12 month cohort was replicated in the six month cohort. 
There was a small overall reduction (of 12 per cent) in the number of Accident and 
Emergency attendances in the six month period following referral to Social 
Prescribing with those patients who had been referred to a funded VCS service 
seeing a greater reduction (0.12 per patient) than the full cohort (0.09) per patient) - 
a difference of 0.03 attendances per patient. Overall, 27 per cent of patients referred 
to a funded VCS service saw a reduction in Accident and Emergency attendances 
compared to 25 per cent of the full cohort. 
Outpatient appointments 
For the 12 month cohort the pattern identified for inpatient admissions and Accident 
and Emergency attendances was replicated in outpatient appointments. There was 
an overall reduction in the number of appointments of 21 per cent in the 12 month 
period following referral to Social Prescribing: patients referred to a funded VCS 
service saw a greater reduction (0.55 per patient) than the full cohort (0.36 per 
patient) - a difference of 0.19 appointments per patient. Overall, 47 per cent of 
patients saw a reduction in outpatient appointments but the proportion was greater 
for patients who had been referred to funded VCS services (55 per cent). 
For the six month cohort the pattern was different to that shown in the rest of the 
analysis. There was a small overall reduction in the number of outpatient 
appointments (of 15 per cent) in the six month period following referral to Social 
Prescribing but the reduction was greater for the full cohort (0.11 per patient) than for 
patients who had been referred to a funded VCS service (0.03 per patient) - a 
difference of 0.8 appointments per patient. Overall, 31 per cent of patients saw a 
reduction in outpatient appointments but the proportion was less for patients who had 
been referred to funded VCS services (30 per cent). 
Conclusion 
Overall, the analysis of patient-level Hospital Episodes Statistics reflects positively on 
the effectiveness of the Social Prescribing Pilot. There was a clear overall trend 
that points to reductions in patients' use of hospital resources after they had 
been referred to Social Prescribing. Furthermore, patients who had been referred 
on to VCS services funded by the Social Prescribing Pilot had generally 
experienced greater reductions than those who either declined a service or were 
referred to 'mainstream' statutory or VCS provision instead. 
At this stage these findings should be viewed positively, particularly in light of the 
consistent patterns identified, but also with some caution: there were too few patients 
in the sample analysed (in the case of the 12 month sample) and too little time had 
elapsed (in the case of the six month sample), to produce findings that are 
statistically significant. Plans for future analysis are outlined in the following section. 
4.3. Future analysis of Hospital Episode Statistics 
Analysis of Hospital Episode Statistics will be undertaken in subsequent years. This 
will aim to build on the existing analysis in a number of ways: 
 analysis of additional patient cohorts 
 analysis of a longer time series 
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 development of a robust control group 
 incorporation of data on use of social and residential care. 
The overall aim will be to generate data that enables more robust and statistically 
powerful analysis. This is discussed in more detail below. 
Additional patient cohorts 
The current analysis focusses on two early cohorts of Social Prescribing patients and 
their utilisation of hospital resources. Over time more patients will be added to these 
cohorts and the impact of Social Prescribing on different cohorts compared. For 
example, it may be possible to compare the progress of patients referred at the 
beginning of the Pilot to patients referred in the later stages, to explore if impact has 
improved as Social Prescribing processes and the range of services available have 
been refined. 
Analysis of a longer time series 
At this stage it has only been possible to compare progress of patients at 12- and six 
months. As the evaluation progresses data over a longer time series will be available 
and analysis of the extent to which impacts improve or last will be possible. 
Developing a robust control group 
The use of a control or comparison group is important for estimating what might have 
happened in the absence of the intervention (the 'counterfactual'). It is particularly 
important in the context of interventions designed to reduce health service utilisation 
as the patients offered such interventions usually have previously experienced high 
levels of service use. Such patients have a natural tendency to show reductions in 
service use over time, even in the absence of a specific intervention.8 This is due to a 
statistical phenomenon called 'regression to the mean'. Although the Social 
Prescribing Pilot involved selecting patients on the basis of a predictive model that 
seeks to take account of this phenomenon, reductions in service use over time are 
nevertheless possible and should be accounted for. 
The gold-standard approach to selecting a control group is the randomised controlled 
trial. This is because randomisation has the potential to balance both observed and 
unobserved characteristics between different groups.9 For this evaluation, however, it 
has only been possible to evaluate the effect on patients who had already received 
the intervention. Other similar studies10 have used large administrative data sources 
to select control groups of patients that appeared similar to their intervention group 
patients in the period prior to the start of the intervention, but who did not receive the 
intervention themselves.  
At this stage, and primarily due to the limits of the resources available for the 
evaluation, such a control group has not been established. We have instead 
explored the progress of two different groups of Social Prescribing referrals: all 
patients referred to Social Prescribing from ICMTs, and a sub-sample of patients 
who received an onward referral to a funded voluntary sector service provider. The 
risk stratification tool used in the referral process sought to ensure that these two 
groups were reasonably similar at the point of referral but the analysis undertaken so 
far suggests there might be something inherently different about these two groups. A 
                                               
8
 Lewis, G et al (2013. Impact of ‘Virtual Wards’ on hospital use: a research study using propensity matched 
controls and a cost analysis. National Institute for Health Research 
9
 Ibid 
10
 Ibid 
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control or comparison group would help mitigate the effects of this difference in any 
future evaluation. 
Going forward, the evaluation will explore the possibilities for accessing 
administrative data, for example through the Health and Social Care Information 
Centre (HSCIC), to develop a more robust external control group. This will enable 
the use of statistical techniques, such as propensity score matching, to develop a 
suitable control or comparison group. 
Incorporating data on use of social and residential care 
There is emerging evidence from the Pilot that being referred to Social Prescribing 
impacts positively on patients' use of social and residential care. This could represent 
a considerable saving to local authority spending on Adult Care Services but in order 
to assess the impact in full additional data would be required. 
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5 5. Social impact 
This chapter draws on a combination of quantitative and qualitative data to provide 
an assessment of the social impact of the Rotherham Social Prescribing Pilot. Two 
data sources provide the basis for this assessment. First well-being outcome data, 
collected by the Pilot from patients, was analysed to identify progress against eight 
separate outcome measures linked to well-being and positive functioning. Second, 
five service level case studies, involving 17 interviews with Social Prescribing 
patients and carers, provided a more detailed insight into the range of social impacts 
associated with the Pilot. 
5.1. Well-being outcomes 
The Social Prescribing Pilot measured patients' progress towards social outcomes 
through a well-being measurement tool developed specifically for the service. The 
tool was completed by VCSAs with patients when they were first referred to the 
service (baseline) with progress measured after approximately three-four months 
(follow-up). It has eight measures associated with different aspects of self-
management:11 
 Feeling positive: hope, learning to cope and feeling calm 
 Lifestyle: sleeping habits, smoking, diet and exercise 
 Looking after yourself: shopping, going out, transport and personal care 
 Managing symptoms: energy levels, pain, information and medication 
 Work, volunteering and other activities: new roles, volunteering and social 
groups 
 Money: debt advice, benefits and managing money 
 Where you live: heating, local facilities, stairs and fire safety 
 Family and friends: isolation, carer support. 
An overview of this outcome data is provided in Table 5.1 with more detailed analysis 
discussed in the sections that follow. 
                                               
11
 For each measure a five point scale was used: 1 = Not thinking about it / not doing anything; 2 = Finding out / 
thinking about; 3 = Making changes / doing something; 4 = Getting there / could do more; 5 = As good as it can 
be. 
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Table 5.1: Overview of well-being outcome baseline and distance travelled data 
Outcome area 
Baseline Distance travelled 
Count Mean 
Low scores*  
(per cent) 
Count Mean 
Progress made  
All 
(per cent) 
Low scores  
(per cent) 
Feeling positive 819 3.08 30 280 3.62 35 61 
Lifestyle 819 3.39 19 280 3.78 25 65 
Looking after yourself 819 3.58 14 280 3.93 24 60 
Managing symptoms 819 3.43 18 280 3.65 21 57 
Work, volunteering and social 
groups 
819 2.49 45 280 3.15 49 54 
Money 819 4.05 10 280 4.39 21 76 
Where you live 819 4.07 8 280 4.39 20 78 
Family and friends 819 3.71 13 280 3.83 27 69 
*A low score is defined as a baseline score of 2 or less
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Baseline analysis 
Between September 2012 and January 2014 baseline data was collected for 819 
patients who were referred to Social Prescribing. In summary this baseline data 
shows that:  
 Feeling positive: the average score was 3.1; 30 per cent of patients recorded a 
low score (of two or less) 
 Lifestyle: the average score was 3.4; 19 per cent recorded a low score 
 Looking after yourself: the average score was 3.6; 14 per cent recorded a low 
score 
 Managing symptoms: the average score was 3.4; 18 per cent recorded a low 
score 
 Work, volunteering and other activities: the average score was 2.5; 45 per 
cent recorded a low score 
 Money: the average score was 4.1; 10 per cent recorded a low score 
 Where you live: the average score was 4.1; 8 per cent recorded a low score 
 Family and friends: the average score was 3.7; 13 per cent recorded a low 
score 
This provides a useful insight into to social support needs of patients at their point of 
engagement with the Pilot. The lowest scoring outcome category was work, 
volunteering and other activities, followed by feeling positive, lifestyle, and managing 
symptoms. This highlights the importance of services that address psycho-social 
factors for people suffering from long-term conditions. 
Distance travelled analysis 
Of the 819 patients for whom baseline data had been collected 280 had been 
followed-up after three-four months. It is on the progress, or 'distance travelled', of 
these 280 patients that the remaining well-being outcome analysis focusses. 
Overall, 83 per cent of patients experienced positive change on at least one 
outcome measure. When the results are broken down by category it shows that 
progress was made against each outcome measure and that a majority of low 
scoring patients (with a baseline score of two or less) made progress: 
 Feeling positive: 35 per cent made progress; of the patients with a low 
baseline score 61 per cent made progress 
 Lifestyle: 25 per cent made progress; of the patients with a low baseline score 
65 per cent made progress 
 Looking after yourself: 24 per cent made progress; of the patients with a low 
baseline score 60 per cent made progress 
 Managing symptoms: 21 per cent made progress; of the patients with a low 
baseline score 57 per cent made progress 
 Work, volunteering and other activities: 49 per cent made progress; of the 
patients with a low baseline score 54 per cent made progress 
 Money: 21 per cent made progress; of the patients with a low baseline score 76 
per cent made progress 
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 Where you live: 20 per cent made progress; of the patients with a low baseline 
score 78 per cent made progress 
 Family and friends: 27 per cent made progress; of the patients with a low 
baseline score 69 per cent made progress. 
Statistical testing 12  was undertaken to explore the statistical significance of the 
proportion of Social Prescribing patients moving from a low baseline score to a high 
score (of 3-5) when followed-up. This demonstrated that the change was statistically 
significant for all but one outcome measure (managing symptoms). This provides a 
high degree of confidence that the outcome change observed represents real 
change, and did not occur due to random chance. 
The distance travelled by Social Prescribing patients across a range of outcomes 
after a relatively short period demonstrates the potential of social interventions to 
address some of the key psycho-social determinants of health. That most progress 
was made against the lowest scoring outcome areas (work, volunteering etc.; and 
feeling positive); and that a majority of low-scoring patients made progress; reflects 
positively on both the effectiveness of the Social Prescribing assessment and referral 
process and the ability of commissioned services to meet the specific social needs of 
patients. 
5.2. Case study findings 
The Interim Report identified a number of examples of social outcomes for Social 
Prescribing clients that emerged during the early stages of the Pilot. These included:  
 patients becoming more independent and able to access social prescribing 
activities with less intensive support 
 patients becoming better at managing their long-term condition themselves 
 patients and carers feeling less socially isolated and enjoying more social 
interaction. 
These findings were identified through interviews with key stakeholders in the service 
such as GPs, social workers, VCS providers and commissioners. They provide an 
illustration of the types of outcomes and impact that might occur more widely as a 
result of social prescribing in the longer term. Since the publication of the Interim 
Report five in-depth case studies have been undertaken with services funded 
through the pilot. Through qualitative interviews with individuals delivering services 
(10 interviews) and beneficiaries of services and their carers (17 interviews), these 
case studies have provided more detailed evidence of social outcomes experienced 
by Social Prescribing patients. An overview of this evidence is provided in the 
following sections, grouped around the four broad outcomes of increased well-being, 
reduced social isolation and loneliness, increased independence, and access to 
wider welfare benefits. In addition, more detailed case study reports are provided in 
Appendix 1. 
Improved well-being 
Improvements in the well-being of patients accessing Social Prescribing services 
emerged very clearly as one of the most important and widely identified benefits of 
the Pilot. Service providers were particularly effusive about the wide ranging well-
                                               
12
 95 per cent confidence intervals were applied. The McNemar test was applied to identify statistically significant 
change between baseline and follow-up outcome scores for each outcome category 
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being benefits they felt beneficiaries experienced and some specific examples of 
these benefits were identified through the interviews with patients and carers. 
Improvements in mental well-being were particularly evident from the case study 
interviews. Mrs A welcomed the opportunity to meet people and interact by attending 
a sensory arts group, and saw is as a "lifeline" in her battle with anxiety and 
depression: 
"If it wasn’t for the group, I might not be here now because I’d been that down 
and depressed….just getting out of the house has helped me with the fear, 
anxiety…talking to people lifts your mood and forget about problems at home".  
Similarly, Mrs B felt that attending a variety of groups and activities funded through 
the Pilot had "got her out of her depression" and Mrs C reflected that the activity she 
attended "makes us feel worthy instead of worthless…feeling less depressed". 
Confidence was another aspect of well-being in which Social Prescribing 
beneficiaries saw improvement. Previously, Mrs C found it difficult to talk to new 
people, but over time she felt she had become more confident whilst attending a 
group and felt more able to play an active role. 
"We talk about various things, about what we’re doing, and how you’re feeling".   
For other beneficiaries a more general sense of positive well-being was evident. 
Prior to her referral to Social Prescribing, Mrs D "was completely stuck" and "didn’t 
know who to go to and what to do" but she subsequently felt "a little better" within 
herself. 
For carers, time and space away from their caring duties was particularly welcome, 
and had a wide range of well-being benefits. For example, prior to her referral to 
Social Prescribing Mrs E wasn’t able to leave her husband and get out of the house 
for more than an hour at a time and was "physically and emotionally exhausted", but 
the additional support had alleviated the pressure somewhat.  
Reduced social isolation and loneliness 
A further benefit of accessing Social Prescribing services, and linked to beneficiaries' 
well-being, was a reduction in social isolation and loneliness. Service providers 
highlighted the importance of linking people with limited mobility and social contact 
with the wider community. This was also highlighted in the interviews with 
beneficiaries. For example, when she was referred Mrs C didn’t expect to get 
anything out of Social Prescribing but has since realised that she now does not feel 
as isolated and was "just looking at four walls without the service" and noted "while 
you’re here you don’t think about your health conditions, you just get on with it". 
Similarly, Mrs F, who received re-abling and befriending support through Social 
Prescribing, valued the additional high quality social contact it provided. 
"It’s someone coming to talk to me and with me and they acknowledge 
me…because you can sit and stare at space and people take no notice 
whatsoever…I feel like I belong to a society". 
Sometimes, activities to reduce isolation and loneliness had wider benefits in terms 
of community engagement and involvement. In one example, Mr A had had a 
number of strokes and spent a lot of time at home. Through Social Prescribing he 
was able to get involved in volunteering, supporting an older peoples indoor bowling 
group, three times a week. This "got him out of the house" and he "enjoyed it, just 
getting out the house for a few hours, sommat to do". 
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Increased independence 
Increased independence was also identified by service providers and beneficiaries 
as an important benefit of Social Prescribing. In particular, those with limited mobility 
were able to become more independent as a result of improvements in their physical 
health. For example, Mr B had suffered a severe stroke three years ago, which 
affected his mobility and his speech, and was told his health may never improve. 
After being referred to Social Prescribing Mr B started going to a gym once a week, 
and participated in activities at the community centre, including creative writing, on 
several other days. Since receiving support through Social Prescribing Mr B had 
become more independent and positive. 
"I was on my own, I was totally on my own…each day I’m getting better and 
better…before I could hardly walk…I’m feeling very positive, each day I get up 
and I just can’t believe how much I’ve come on". 
Similarly, Mrs G was referred to an exercise class and her mobility improved 
significantly. As a result she had "regained some independence", and felt better 
physically and emotionally because she had "something to look forward to". Without 
Social Prescribing, Mrs G believed she would withdraw within herself and become 
isolated again. 
There have also been examples of beneficiaries becoming involved in independent 
social and community action since accessing Social Prescribing services. Mrs A, for 
example, from taking tentative steps when accessing Social Prescribing services for 
the first time, has become a proactive member of the group and has produced a 
Facebook account for the group to display their artwork. Linked to this, Mrs B 
reported examples of self-help and mutual aid within the group she attended, with 
members doing shopping for each other when carers or family members have been 
unavailable. Mrs H, who cares for her partner, provided similar reflections. 
"I can go out and I’ve got peace of mind and I know he’s alright and he’s safe 
and there’s somebody with him…I feel better". 
Access to wider welfare benefits 
A final area of outcomes associated with access to Social Prescribing services was 
the ability of beneficiaries to access wider welfare benefits. The role of advocacy 
services was particularly important in making beneficiaries and their carers aware of 
various benefits that could be available to them and supporting them to make 
applications. For example, Mrs D has literacy problems and her benefits were 
stopped at short notice. Through Social Prescribing she was able to access an 
advocate who helped her complete benefit forms and to apply for a free bus pass. 
Similarly, Mrs G and her family were supported to apply for Direct Payments to 
increase the frequency of the carer support available to them. For Mrs D and Mrs G, 
gaining access to these benefits and the wider support they enabled was key to their 
subsequent realisation of other outcomes, such as improved well-being (in the case 
of Mrs D) and independence (Mrs G). 
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6 6. Economic and social cost-
benefits 
This chapter provides a monetised assessment of the economic and social cost-
benefits of the Social Prescribing Pilot. The economic cost-benefits are estimated 
based on analysis of the Pilot's effect on patients' use of hospital care (Chapter 4). 
Social cost-benefits (social value) are estimated based on analysis of the Pilot's 
social impact (Chapter 5), using well-being outcome data and information about 
volunteers, welfare benefit claims and additional funding access, collected through a 
survey of funded VCS providers. 
6.1. The costs of the Social Prescribing Pilot (inputs) 
Overall the Social Prescribing Pilot cost £1,099,792. A more detailed breakdown is 
provided in Table 6.1 
Table 6.1: Overview of Social Prescribing Pilot Costs (2012-14) 
 
Year 1  
(Apr 12-Mar 13) 
Year 2  
(Apr 13-Mar 14) 
Total 
Grants to Providers £301,727 £204,540 £506,266 
Additional Support Grants £11,265 £93,066 £104,331 
VAR costs (salaries/overheads 
etc.) 
£216,182 £273,012 £489,194 
Total £529,174 £570,618 £1,099,792 
These costs provide the basis for the social and economic cost-benefit analysis that 
follows in this chapter. They represent the direct costs (inputs) of commissioning the 
Pilot to the CCG. However, it should be noted that a range of other indirect costs 
(inputs) have been borne by different stakeholders in the pilot: 
 Voluntary Action Rotherham and the CCG: invested a significant amount of 
time prior to the commissioning of the pilot to research need for the service, 
develop the service model and specification, and consult with GPs and voluntary 
sector organisations. 
 The Foundation Trust: supported the development of a complex client 
management system (database) through which referrals in to and out of the 
service were monitored and reported on. Support for the maintenance of this 
system is ongoing. 
 Centre for Regional Economic and Social Research | 28 
 Volunteers: many of the services provided through the Pilot were provided with 
considerable support from volunteers. They input their own time, without which 
the direct costs of delivering the Pilot would have been far higher. The value of 
this time input is discussed later in this chapter. 
Although these costs have not been calculated and included in the cost-benefit 
analysis, it is important that they are considered alongside direct monetary costs. 
6.2. The economic benefits of the Social Prescribing Pilot 
This section considers the economic cost-benefits of the Social Prescribing Pilot. 
Three types of NHS cost are considered: 
 hospital admissions (inpatient stays) 
 Accident and Emergency attendances 
 outpatient appointments. 
Methodology 
Activity was costed using the 2013/14 Payment by Results (PbR) national tariff.13 In 
cases where the activity did not have a tariff, costs were estimated from the NHS 
reference costs.14 These tariffs represent the cost to the commissioner of care, rather 
than the actual costs of providing care. This approach to costing is consistent with a 
number of studies undertaken for the NHS Institute for Health Research.15 
The costs of inpatient admissions were established by calculating the Healthcare 
Resource Group (HRG) for each patient’s whole stay in hospital. The PbR rules were 
used to combine the HRG, admission type and other details of the hospital stay. This 
included the unit cost of the HRG, including where the reduced short stay emergency 
was applied and payments were due because of an unexpectedly long stay in 
hospital (i.e. where the trimpoint was exceeded). Accident and Emergency costs 
were also calculated as recommended by the PbR rules, with outpatient costs 
derived from NHS reference costs. 
Following the calculation of costs, analysis was undertaken on similar basis to that 
presented in Chapter 4. For the 12 month sample the cost of each type of episode 
was compared for the 12 month periods before and after referral to Social 
Prescribing. For the six month sample the costs of the six month periods before and 
after referral were compared.  
Cost comparisons 
An overview of the cost comparisons is provided in Tables 6.2 and 6.3. Comparisons 
are provided for each type of hospital episode and for the total costs associated with 
all episodes. As in Chapter 4, figures are provided for all referrals to Social 
Prescribing and the sub-group of patients who were referred on to a funded VCS 
provider. 
 
                                               
13
 NHS PbR guidance is available online at: 
 https://www.gov.uk/government/publications/payment-by-results-pbr-operational-guidance-and-tariffs  
14
 NHS Reference Costs are available online at https://www.gov.uk/government/collections/nhs-reference-costs  
15
 See for example: Lewis, G et al (2013. Impact of ‘Virtual Wards’ on hospital use: a research study using 
propensity matched controls and a cost analysis. National Institute for Health Research 
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Table 6.2: Per-patient utilisation of hospital resources: cost comparison - 12 
month cohort 
 
All patients referred to 
Social Prescribing 
Patients referred to a grant 
funded VCS provider 
12m 
before 
12m 
after 
Change 
12m 
before 
12m 
after 
Change 
Cost of  
inpatient 
admissions 
£2,633 £2,434 -£198 £2,282 £2,001 -£281 
Cost of A&E  
attendances 
£201 £174 -£27 £221 £183 -£38 
Cost of 
outpatient 
appointments 
£184 £145 -£39 £206 £147 -£59 
Total cost £3,018 £2,753 -£265 £2,708 £2,330 -£378 
Table 6.3: Per-patient utilisation of hospital resources: cost comparison - six 
month cohort 
 
All patients referred to 
Social Prescribing 
Patients referred to a grant 
funded VCS provider 
6m 
before 
6m 
after 
Change 
6m 
before 
6m 
after 
Change 
Cost of  
inpatient 
admissions 
£1,112 £1,098 -£14 £1,058 £896 -£162 
Cost of A&E  
attendances 
£81 £73 -£8 £82 £70 -£12 
Cost of 
outpatient 
appointments 
£80 £68 -£12 £78 £75 -£3 
Total cost £1,273 £1,239 -£34 £1,218 £1,040 -£178 
Per-patient cost reductions have been identified in both cohorts but the cost 
reductions are considerably greater for the group of patients that had been referred 
on to a funded VCS provider: 
 in the 12 month cohort there was an overall cost reduction of £265 per patient 
but the per patient cost reduction for patients referred to a funded VCS service 
was £378 
 in the six month cohort there was an overall cost reduction of £34 per patient but 
the per patient cost reduction for patients referred to a funded VCS service was 
£178. 
The total cost reduction figures for the 12 month cohort provide the basis for an 
estimate of the annual economic cost-benefits to the NHS presented in the following 
section. 
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Estimated cost-benefits 
Annual cost-benefits were calculated through a two stage process to capture the fact 
that patients who were referred to funded VCS services demonstrated, on average, 
greater cost reductions than those who were not: 
1. The cost-benefits associated with patients who were referred on to funded VCS 
provision were calculated: by multiplying the per-patient cost reduction for this 
sub-group (£378) by the total number of referrals to grant funded providers 
across each year of the pilot (Year 1=217; Year 2=901). 
2. The cost-benefits associated with referrals to Social Prescribing who were not 
referred on to VCS provision were calculated: by multiplying the overall per-
patient cost reduction (£265) by the remaining number of referrals to Social 
Prescribing across each year of the pilot (Year 1=208; Year 2=281). 
The analysis therefore assumes that the cost reductions identified for the 12 month 
samples are representative of Social Prescribing as a whole, and that being referred 
to a funded VCS service is more beneficial than not being referred on. Table 6.4 
provides an overview of the estimated annual cost reductions identified. 
Table 6.4: Overview of estimated annual cost reduction associated with the 
utilisation of hospital resources 
Patients referred to a grant 
funded VCS provider 
Patients not referred to a 
funded VCS provider 
Per 
patient  
Year 1 
total 
Year 2 
total 
Per 
patient  
Year 1 
total 
Year 2 
total 
£378 £82,026 £340,578 £265 £55,120 £74,465 
These values can be compared with the costs of delivering the Social Prescribing 
Pilot to provide an estimate of the annual return on investment provided (Table 6.5). 
Table 6.5: Estimated annual return on investment (ROI) from NHS cost 
reductions  
 Costs Benefits 
ROI 
 Input costs 
Patients referred to 
a grant funded VCS 
provider 
Patients not 
referred to a funded 
VCS provider 
Total 
Year 1  
(Apr 12-Mar 13) 
£529,174 £82,026 £55,120 £137,146 0.26 
Year 2 
(Mar 13-Apr 14) 
£570,618 £340,578 £74,465 £415,043 0.73 
All years £1,099,792 £422,604 £129,585 £552,189 0.50 
This demonstrates that the estimated annual NHS cost reduction for the two 
years of the pilot was £552,189 compared to total input costs of £1.1 million. This 
translates to an annual return on investment of 0.50 (50 pence for each pound 
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invested). However, it is important to note that the Year 1 figures do not provide an 
accurate reflection of the likely cost-benefits of Social Prescribing over a longer 
period. This is because of the considerable time that elapsed between the 
commissioning of the Pilot and the first referrals-in (circa five months) and the first 
referrals-out (circa eight months). As such the number of referrals was far lower than 
in Year 2 of delivery which encompassed a full 12-month period. Therefore, when 
considering the likely cost-benefits that will occur during future years of delivery it 
would more realistic to use the figures for Year 2 rather than the combined figured for 
both years. This provides a much higher estimated annual return on investment of 
0.73 (73 pence for each pound invested) 
Using these figures as a basis for longer-term projections, and assuming that the 
benefits identified are sustained over a longer period, the costs of delivering the 
service for a year could be recouped by commissioners after 18 to 24 months. 
Table 6.6 demonstrates how these benefits might accumulate over a longer period 
(up to five years).  
Table 6.6: Estimated long-term return on investment (ROI) from NHS cost 
reductions 
 
1: Benefits last for 5 
years 
2: Benefits drop-off at 
20 per cent per year 
3: Benefits drop-off at 
33 per cent per year 
Cumulative 
value 
ROI 
Cumulative 
value 
ROI 
Cumulative 
value 
ROI 
Year 1 £415,043 0.73 £415,043 0.73 £415,043 0.73 
Year 2 £815,559 1.43 £735,456 1.29 £679,384 1.19 
Year 3 £1,201,549 2.11 £967,050 1.69 £806,761 1.41 
Year 4 £1,573,013 2.76 £1,115,636 1.96 - - 
Year 5 £1,929,950 3.38 £1,187,023 2.08 - - 
This shows that, for each year of full service delivery: 
 if the full benefits last for five years they could lead to total cost reductions of 
£1.9 million: a return on investment of 3.38 (three pounds 38 pence for each 
pound invested) 
 if the benefits are sustained but drop-off at a rate of 20 per cent each year they 
could lead to total cost reductions of £1.2 million: a return on investment of 2.08 
(two pounds and eight pence for each pound invested) 
 if the benefits are sustained but drop-off at a rate of 33 per cent each year they 
could lead to total cost reductions of £807,000: a return on investment of 1.41 
(one pound and 41 pence for each pound invested). 
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6.3. The social benefits (social value) of Social Prescribing 
This section considers the social cost-benefits, or social value, of the Social 
Prescribing pilot. It uses financial proxies to provide a monetised assessment of 
social impact arising from the pilot. Four aspects of social value are considered: 
 the well-being benefits for Social Prescribing patients 
 the volunteering associated with the pilot 
 the additional welfare benefits claimed by Social Prescribing patients 
 additional funding accessed by funded VCS services providers that can be 
attributed to their involvement in the pilot. 
The value of well-being benefits 
The approach to monetising well-being draws on social value work undertaken by 
the New Economics Foundation and New Economy Manchester 16  to value the 
subjective well-being benefits associated with social interventions. Well-being is 
equated with mental health to enable the use of health economics to monetise the 
social value created. Analysis by the Centre for Mental Health17 placed a cost on 
mental illness through the use of QALYs (Quality Adjusted Life Years), derived from 
a measure of health related quality of life. Their analysis identified the average loss 
of health status in QALYs from a level-three mental health problem (a severe 
problem - 0.352 QALYs) and valued this by using the NICE (National Institute for 
Health and Clinical Excellence) cost effectiveness threshold of £30,000 per QALY. 
Equating well-being with mental health therefore provides an overall well-being 
valuation of £10,560 per year (0.352 x £30,000). As the Pilot did not use a 
recognised QALY-based social value tool (such as EQ-5D), the well-being outcome 
tool was used as a proxy measure of well-being and health related quality of life. 
It is important to note that measurement of subjective well-being is a relatively new 
discipline, and there have been relatively few attempts to value well-being. In 
particular, it is recognised that using mental health as a proxy for well-being may not 
be the most accurate way of determining the true value of well-being. Likewise the 
well-being outcome tool cannot be considered as accurate a measure of health-
related quality of life as the validated tools used in health economics. As such the 
findings presented here should be considered experimental, and the methodology for 
valuing the well-being benefits of Social Prescribing will be refined as the project 
progresses. 
Methodology 
As a start point, it was assumed that each category on the well-being outcome tool 
provided an equal contribution to well-being. As such, the total value of well-being 
was distributed evenly across the outcomes (£1,320 per outcome). Two approaches 
to valuing the well-being benefits were then taken. In the first approach, all outcome 
change was valued, and it was assumed that a one point change on each outcome 
measure equated to 20 per cent of the outcome value. In this approach a client 
progressing one point on an outcome measure accrued £264 of social value while a 
client progressing five points accrued £1,320. In the second approach outcome 
change was only valued for clients who progressed from a low score (of two or less) 
                                               
16
 Cox, J et al (2012) Social Value: Understanding the wider value of public policy intervention. New Economy 
Working Paper 008 
17
 Centre for Mental Health (2010). The economic and social costs of mental illness, (June 2003, updated 
October 2010) 
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to a high score (of three or more). In this approach a client progressing from low to 
high on the each outcome measure accrued the full social value of £1,320. In both 
approaches the equivalent amount of negative value was allocated to negative 
outcome change. This process is summarised in Table 6.7. 
Table 6.7: Allocation of financial proxies 
Proportion of overall value 
(£10,560) per outcome (%) 
1: Valuing all outcome 
change 
2: Valuing low to high 
outcome change 
Value of a 1pt change  
(+/-) 
Value of low to high change  
(+/-) 
12.5 £264 £1,320 
An estimate of the well-being value created 
An overview of the estimated well-being value created for patients in the Social 
Prescribing Pilot is provided in Tables 6.8 and 6.9. The total value was calculated by 
multiplying the per-patient value by the total number of referrals to grant funded 
providers across each year of the pilot (Year 1=217; Year 2=901).  
Table 6.8: Overview of the estimated annual well-being value created by 
outcome  category 
Outcome area 
 
1: Valuing all outcome change 
2: Valuing low to high outcome 
change 
Per 
patient 
value 
Year 1 
value 
Year 2 
value 
Per 
patient 
value 
Year 1 
value 
Year 2 
value 
Feeling positive £139 £30,163 £125,239 £199 £43,183 £179,299 
Lifestyle £66 £14,322 £59,466 £69 £14,973 £62,169 
Looking after 
yourself 
£65 £14,105 £58,565 £93 £20,181 £83,793 
Managing 
symptoms 
£42 £9,114 £37,842 £31 £6,727 £27,931 
Work, 
volunteering and 
social groups 
£184 £39,928 £165,784 £214 £46,438 £192,814 
Money £80 £17,360 £72,080 £93 £20,181 £83,793 
Where you live £68 £14,756 £61,268 £49 £10,633 £44,149 
Family and 
friends 
£89 £19,313 £80,189 £75 £16,275 £67,575 
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Table 6.9: Overview of the estimated annual well-being value created by year 
 
1: Valuing all outcome 
change 
2: Valuing low to high 
outcome change 
Year 1  
(Apr 12-Mar 13) 
£159,061 £178,591 
Year 2  
(Mar 13-Apr 14) 
£660,433 £741,523 
All years £819,494 £920,114 
It shows that the two approaches to valuation provided very similar results: valuing 
all outcome change produced an estimated total annual well-being value of £819,000; 
valuing only low-to-high outcome change produced an annual value of £920,000. 
These values can be compared with the costs of delivering the Social Prescribing 
Pilot to provide an estimate of the annual return on investment provided (Table 6.10). 
Table 6.10: Estimated annual return on investment (ROI) from well-being 
benefits 
 
Input 
costs 
1: Valuing all outcome 
change 
2: Valuing low to high 
outcome change 
Total value ROI Total value ROI 
Year 1  
(Apr 12-Mar 13) 
£529,174 £159,061 0.30 £178,591 0.34 
Year 2 
(Mar 13-Apr 14) 
£570,618 £660,433 1.16 £741,523 1.30 
All years £1,099,792 £819,494 0.75 £920,114 0.84 
This demonstrates that the estimated return on investment from well-being benefits 
for the two years of the Pilot was between 0.75 and 0.84 (between 75 pence and 84 
pence per pound invested). In Year 1, the estimated return on investment was 
between 0.30 and 0.34 (between 30 pence and 34 pence per pound invested) and in 
Year 2 it was between 1.16 and 1.30 (between one pound and 16 pence and one 
pound and 30 pence per pound invested). This means that in Year 2 of the Pilot the 
estimated well-being value created was greater than the input cost of delivering the 
service. 
As with the NHS cost reductions, it is important to note that the Year 1 figures do not 
provided an accurate reflection of the likely social cost-benefits of Social Prescribing 
over a longer period. This is because of the considerable time that elapsed between 
the commissioning of the Pilot and the first referrals-in (circa 5 months) and the first 
referrals-out (circa 8 months). As such the number of referrals was far lower than in 
Year 2 of delivery which encompassed a full 12 month period. Therefore, when 
considering the likely social cost-benefits that will occur during future years of 
delivery it would more realistic to use the figures for Year 2 rather than the combined 
figure for both years. On this basis, a positive social return on investment based 
on the well-being benefits experienced by patients would be achieved during 
the first year post referral. 
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The value of volunteering 
Volunteering was a key feature of the Social Prescribing Pilot. It is estimated that, 
overall, 81 volunteers each contributed an average of three and a half hours of 
their time per week to services funded by the Pilot: this is the equivalent of around 
seven FTE employees. This contribution has considerable value that can be 
estimated based on the value of the input provided by volunteers:18  the amount that 
it would cost to pay employees to do the work carried out by volunteers.19 There are 
a number of hourly rates that could be used to estimate this value; these include: the 
national minimum wage, the local median wage, the local mean wage and the 
reservation wage. The latter, the hourly rate associated with the actual role of 
volunteers is the preferred option; however the data available does not enable an 
accurate calculation using this method. Therefore the preference in this study has 
been to provide a range using the national minimum wage20 (low estimate) and the 
local median wage21 (high estimate). In reality the true value of the input provided by 
volunteers will lie between the two estimates. 
On this basis, it is estimated that the annual value of volunteering undertaken during 
delivery of the Social Prescribing Pilot was worth: 
 £81,000 based on the national minimum wage 
 £148,000 based on the national median wage. 
This represents an additional £0.14 - £0.26 (14-26 pence) for each pound invested in 
the Pilot by the CCG. 
The value of additional welfare benefits 
VCS service providers in receipt of funding through the Social Prescribing Pilot 
supported referred patients to claim an additional £350,000 in welfare benefits over 
the course of the Pilot. Benefits claimed included Attendance Allowance, Direct 
Payments, Carer's Allowance, Housing Benefit, Personal Independence Payment, 
and Employment Support Allowance. The case study evidence demonstrates that in 
many cases these patients would not have been aware of their entitlement to these 
benefits, or how to claim them, without the services, support and advocacy received 
through Social Prescribing. 
The value of additional funding to VCS providers 
Two VCS service providers in receipt of funding through the Social Prescribing Pilot 
were able to secure additional funding as a result of their Social Prescribing grant: 
one provider received £180,000 from the Big Lottery Fund (BLF), one received 
£10,000 from NHS England and another received £10,000 from Awards for All (BLF 
small grants fund). In addition, 11 funded VCS service providers reported that Social 
Prescribing patients had accessed additional services though self-funding or by 
using their Direct Payments or Personal Budgets: the value of this additional income 
was at least £10,000 over the course of the pilot. 
                                               
18
 This is the value of volunteering to the organisations providing funded Social Prescribing services and 
therefore the value of volunteering to the Pilot. It is the approach recommended by Volunteering England (now 
part of NCVO). 
19
 This assumes that there are no additional costs faced by organisations in using volunteers: for example extra 
management costs. 
20
 £6.31 per hour from October 2013. 
21
 £11.56 in 2013 (the Annual Survey of Hours and Earnings provides a wide range of information on hourly, 
weekly and annual earnings of employees April 2013). 
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7 
 7. Conclusion 
This report has provided a detailed assessment of the economic and social impact of 
the Rotherham Social Prescribing Pilot. It builds on an earlier Interim Evaluation 
report which identified emerging lessons from the Pilot and provided insights from the 
perspective of key stakeholders. This final concluding chapter draws together 
findings from both reports to provide an overall assessment of the Pilot and highlights 
some implications for future service delivery and commissioning. It discusses in turn: 
 outcomes for Social Prescribing patients and their carers 
 outcomes for the public sector 
 outcomes for the local voluntary and community sector 
 implications for future service delivery and commissioning 
 next steps for evaluation. 
7.1. Outcomes for Social Prescribing patients and their carers 
The Pilot reached more than 1,500 local people with long-term health conditions. A 
large majority of these patients and their carers experienced positive health and well-
being outcomes. Since being referred to Social Prescribing patients' and carers' 
mental health has improved, they have become more independent, less isolated, 
more physically active, and have begun engaging with and participating in their local 
community. They have also been able to access a range of welfare benefits that they 
were previously unaware of. Crucially, Social Prescribing services have provided 
these patients and carers with an important first step to engaging with community-
based services and wider statutory provision that they would not otherwise have 
been aware of or able to access. 
7.2. Outcomes for the public sector 
Patients accessing the Pilot were already high users of hospital care and assessed 
as at high risk of accessing unplanned hospital care in the future: in the 12 months 
prior to referral Social Prescribing patients 22  cost commissioners an average of 
£3,018 per client in inpatient stays, Accident and Emergency attendances and 
outpatient appointments alone; by comparison, the NHS Confederation estimated 
that the money spent per capita on all NHS services in England was £1,979 in 
2010/11. 23  The importance of demonstrating the ability of Social Prescribing at 
reducing patients' use of hospital care can therefore not be underestimated and is 
regarded as an important measure of success by local NHS commissioners. 
                                               
22
 Estimate based on data for the 12 month cohort 
23
 http://www.nhsconfed.org/resources/key-statistics-on-the-nhs Last accessed 15 July 2014 
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So far the evaluation evidence is very positive. Social Prescribing patients' use of 
hospital resources, measured through the number of inpatient stays, Accident and 
Emergency attendances and outpatients appointments, reduced by up to fifth in the 
12 month period following their referral to Social Prescribing. This translates into 
potential positive financial returns to commissioners in a relatively short period 
following the initial referral. However, at this stage these findings carry an important 
caveat: there are too few patients analysed and too little time has elapsed to produce 
findings that are statistically significant. In 12 months' time it will be possible to 
produce more statistically robust evidence, as a larger number of patients will have 
been tracked over a longer period. 
In addition to these direct health related resource and cost benefits, the public sector 
has experienced broader outcomes as a result of the Social Prescribing Pilot. For 
example, patients accessing the service are generally more satisfied with the support 
they received and feel better supported to manage their condition. Furthermore, there 
is emerging evidence that non-health services, in particular social and residential 
care, benefit from similar reductions in resource utilisation and service delivery costs. 
However, detailed analysis of social care data would be needed to properly quantify 
the extent of these reductions. 
7.3. Outcomes for the local voluntary and community sector 
Although not an intended direct beneficiary of the Social Prescribing Pilot, the local 
voluntary and community sector (VCS) has also benefitted. For example, the £0.6 
million that was invested in VCS Social Prescribing services has been a catalyst for 
innovation in community-level service provision, enabling small organisations without 
a track record in health service provision to access NHS funding for this first time. 
Some of these providers have been able to 'match' their Social Prescribing with 
income from other sources, including National Lottery grants, public sector contracts, 
Direct Payments and self-funders, to enhance their provision and improve the overall 
sustainability of their organisation. Overall, the Pilot has demonstrated the potential 
for relatively small community-based provision to make a positive and cost-effective 
contribution to local strategic health and well-being priorities, and ought to provide a 
strong foundation for these types of providers to continue making a positive 
contribution through commissioned services in the future. 
7.4. Implications for future service delivery and commissioning 
The Social Prescribing Pilot and the evidence collected as part of the evaluation, 
have some important implications and lessons for future public service delivery and 
commissioning involving the VCS in health, social care, and more broadly. 
Demonstrating social value through commissioning 
Under the provisions of the Public Service (Social Value) Act 201224 statutory bodies 
are required to consider during commissioning and procurement 'how what is 
proposed to be procured might improve the economic, social and environmental well-
being of the relevant area', and, 'how, in conducting the process of procurement, it 
might act with a view to securing that improvement'. This evaluation has 
demonstrated the types of social value that can be created through public services 
commissioned through the VCS. These include reductions in the utilisation (and 
ultimately cost) of public services, improvements in the health and well-being of local 
people, independent community engagement and social action, wider economic 
                                               
24
 See http://www.legislation.gov.uk/ukpga/2012/3/enacted for the full wording of the Act 
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benefits in the form of welfare entitlements and funding, and a more sustainable, 
vibrant and innovative local VCS. It is important to note that this social value is 
accrued by a range of different stakeholders (not just commissioners and 
beneficiaries) and is not always a direct aim of the service that has been 
commissioned. Therefore, as local statutory bodies implement the Act going forward, 
they should be encouraged to consider the social value that could accrue for a range 
of different stakeholders in the service being commissioned, and ensure that this is 
embedded in procurement processes. 
The role of local infrastructure in micro-commissioned community services 
The central role played in the Social Prescribing Pilot by the local VCS infrastructure 
organisation, Voluntary Action Rotherham (VAR), has come through very clearly 
through the evaluation. First, VAR played a key role in getting the Pilot up and 
running through strong partnership working with the NHS PCT/CCG and local VCS 
organisations, building on relationships, trust and understanding that had been 
developed over a number of years. Second, VAR has been the accountable body (or 
prime contractor) responsible for delivering the Pilot on behalf of the CCG. This has 
included developing the Social Prescribing 'model' enacted in Rotherham, 
establishing the systems and processes necessary for the pilot to function effectively, 
and micro-commissioning the community services required to deliver the Pilot.  
Commissioners, health and care professionals and VCS providers have been 
overwhelmingly positive about VAR's role in delivering the pilot. In particular they 
have valued VAR's professionalism, independence, adaptability and, perhaps most 
importantly, their knowledge and understanding of the VCS in the borough and how 
its potential could be unlocked to deliver the Pilot effectively. As a result, the Pilot 
provides a model for future 'micro-commissioning' of community level services across 
a wide range of public service areas. 
7.5. Next steps for evaluation 
This is the final output of the Evaluation of the Social Prescribing Pilot but it has 
clearly demonstrated that the role for evaluation within the Pilot should continue if the 
long-term benefits of the investment in the service are to be fully understood. 
Ongoing evaluation will need to track Social Prescribing patients for a longer period 
post referral. Although patients need to be tracked for a minimum of 12 months post 
referral to identify the immediate benefits of Social Prescribing, there is also merit in 
tracking patients for a longer period (at least 2-3 years) to understand the extent to 
which benefits drop-off, are sustained, or are enhanced. In addition, the development 
of a control or comparison group would improve the statistical reliability of any data 
analysis and should be a priority for future evaluative work. 
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Appendix 1: Case Studies 
Case Study 1: Crossroads Care 
Organisation 
Crossroads Care is a registered charity and a network partner of the Carers Trust. The 
organisation was established in 1990 in Rotherham and its main role is to provide support to 
carers, which (apart from complementary therapies provision) takes place in the client's own 
home.  Support is tailored to the individual family; this involves a home visit and a discussion 
with the carer and the person they care for, and attempts are made to closely match staff 
with the carer's needs because support is usually provided over a long period of time. A
dementia service and an end of life service are also provided, funded through NHS 
Rotherham CCG. Although Crossroads Care is part of the voluntary and community sector, 
all staff are fully trained and paid.  
Services provided through Social Prescribing  
The service provided through Social Prescribing benefits particular types of carers: the 
majority are supporting somebody with dementia.  Although most carers want a respite 
service, long-term funding for intensive support is limited, so Crossroads have developed an 
alternative model to support carers. Although a small amount of respite is available, the new 
model focuses on teaching people to manage better through a programme of training and 
stress reduction, as well as respite. A menu of options is available for carers, which includes:  
 flexible respite (30 hours over an eight week period)  
 four complementary therapy sessions 
 various training options such as 'Moving & Handling', 'Health & Safety' and 'Caring 
with Confidence' training 
 information and signposting 
 a coffee morning to bring carers together is also being set up.  
This model of provision differs from their usual services because it is short-term and the aim 
is to help carers develop skills and capacities to manage and cope in their caring role, as 
well as providing some respite. 
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Patient case studies 
Mrs A 
Mrs A is 76 years old and lives with her husband, for whom she is a full-time carer. He was 
diagnosed with dementia 7 years ago and since then his health has deteriorated rapidly. As 
a result, he struggles with: his mobility; memory; his breathing; feeding himself; and 
sleeping.  He is restless, frustrated, prone to falls and injuries, and Mrs A struggles to gain 
his cooperation for the sake of his own safety, ‘He doesn’t want to sit; he’s up and down, up 
and down’. She has been providing him with round-the-clock care and supervision. Her son 
helps out occasionally and her daughter takes her out from time to time. The care she 
receives through Social Services doesn’t meet her needs adequately; some carers arrive 
when Mrs A has done the difficult task herself, for example, getting him ready for bed. She 
likes reading and researching places of interest on the internet, but has very little time to 
devote to these activities. Her husband’s needs precede her own needs, for example, she 
booked an appointment at a Well Woman clinic which was cancelled when her husband 
suddenly went into hospital. 
A GP at the memory service referred Mrs A to Crossroads Care in August; a risk 
assessment was undertaken and a care plan was produced based on Mrs A and her 
husband’s needs. As well as providing support and advice, a carer was matched to the 
household’s needs. Since then, respite care is usually provided for four hours once every 
week to allow Mrs A time to herself, and this has meant a lot to her ‘because I can go out’.  
Usually, a total of 30 hours of respite care is provided through the Social Prescribing service 
but this was extended in Mrs A’s case because she clearly needed more support. Without 
the Crossroads service, she wouldn’t be able to get out for more than an hour at a time 
 
Mrs B 
Mrs B is 72 years old and lives with, and provides care for, her partner who has Alzheimer's. 
Apart from attending day care once a week, the burden of his care has fallen on Mrs B and 
this has left her feeling isolated and ‘a bit lost’. She has very limited support from family. She 
used to go to art and cake decorating classes before Mr B got ill, to get out and socialise, but 
it isn’t possible anymore, ‘I don’t matter really, I feel like that’.  
Her GP referred her to a VCSA who then referred her to Crossroads Care after assessing 
her needs.  They undertook a risk assessment and produced a care plan based on Mrs B 
and her partner’s needs. A carer was matched with the family, who visits once a week and 
occasionally, twice a week. The Social Prescribing service provides 30 hours of respite care 
over 8 weeks and there is some flexibility in the service in that patients can request a break, 
and then continue. In addition to referring her for respite, her GP also arranged for Mr B to 
attend a memory clinic. 
The communication between Mr B and the Crossroads carer is good. A male carer is more 
suitable for Mr B, as he can be aggressive at times. Having the same carer and the 
familiarity helps build trust and a mutual understanding. The Crossroads respite care ‘means 
a lot really. I can go out and I’ve got peace of mind and I know he’s alright and he’s safe and 
there’s somebody with him’. ‘I feel better'. Mrs B tries to coordinate her visits from the 
Crossroads carer with her regular hospital appointments, which she has for the treatment of 
a liver condition. Although the Social Prescribing service has not reduced her use of 
GP/hospital visits, this crisis support has clearly been important and could prevent the 
requirement for medical intervention in the longer term. ‘A few weeks ago I did come to a 
boiling point. One thing had happened after another and I thought that’s just finished me off’. 
She rang Crossroads and they put her in contact with an organisation, for a week of 
emergency respite care. Crossroads also provided her with information about coffee 
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mornings and complementary therapies for some rest and relaxation. 
Mrs C 
Mrs C is 61 years old and lives with her partner. She has been providing care for her father, 
at his home (1.5 miles away), on a daily basis since April 2013.  He has Alzheimer's and is 
partially sighted. Initially, Mrs C’s father had two two-hour carer sessions per week provided 
by Social Services, which were withdrawn, and he also had four 30 minute visits per day and 
these have been cut down to four 15 minute visits, so his care has been reduced 
significantly. This has had a significant impact on Mrs C because she has to be more readily 
available to provide support. She does the washing; cleaning; shopping; takes him to his 
medical appointments; to the barbers; takes him to draw his pension; she handles all his 
financial affairs and pays his bills. ‘It makes me tired, it makes me worried, it makes me feel 
guilty at times….trying to fulfill two roles, and you tend to put yourself last’. She has lost 
weight; feels exhausted; stressed; tearful; and feels frustrated. This has affected: her 
relationship with her partner; her diet, because she doesn’t cook anymore and only eats 
ready meals; her personal care due to a lack of time; and her ability to look after her own 
health.  
There are no other family members to help out, so Mrs C sought help, this involved making 
numerous phone calls and leaving messages, ‘spending hours and hours trying to find out 
where I could go to get any sort of help from, to me if there’s a central point whose got that 
information readily available they can come and say to you this might suit you, or that might 
suit you’.  Eventually, she was referred by her GP to a VCSA. The Crossroads Care 
Coordinator ‘came and gave us the opportunity to say what we would like, so we got the 30 
hours of respite care’. The respite care alleviated some pressure, ‘but then the unfortunate 
thing is, it comes to an end and what do you do when it comes to an end?’ Without this 
service, Mrs C would have to dedicate most of her time, every day, to care for her father 
because he is so dependent and needs practical care as well as requiring company because 
he is lonely.  
The Crossroads Care service offers Mrs C consistency by sending the same person every 
time, ‘my dad got to know x, he liked him coming, they got used to each other, he felt 
comfortable with that’. Through social prescribing, her father has accessed the Rotherham 
United Community Sports Trust for gentle exercise at home, the organisation Sense for arts 
and crafts, and the Royal Voluntary Service befriending scheme. Through Crossroads Care, 
Mrs C was also able to benefit from four massage sessions, which were therapeutic, ‘you do 
feel as though you’ve come down, you lose the tightness that you carry around with you 
permanently’. 
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Case Study 2: Age UK Rotherham 
The organisation 
Age UK Rotherham is an independent charity whose objective is to make the lives of older 
people in Rotherham as fulfilling and rewarding as possible. The organisation was 
established in 1978 and its main role is to provide a diverse range of services for older 
people including: hospital aftercare; domestic service; gardening; handypersons service; 
advice and information; a re-ablement service; security protection; befriending; and a social 
centre provided in the community.  
Services provided through Social Prescribing  
The social prescribing services provided by Age UK mainly support older people (over 55) 
who are socially isolated: 
 a reablement service, based on the organisation’s existing hospital aftercare service, 
aims to prevent readmission, preventing visits to GPs and district nurses. This involves 
an assessment of day-to-day activities such as washing and dressing; if an individual is 
struggling with a particular problem, they are supported to regain their independence. 
 a befriending service utilises volunteers to support older people feeling lonely and 
isolated. Volunteers visit an individual they have been matched with on a regular basis 
to build up a relationship and help build confidence and promote some independence. 
Ten visits per person have been funded by Social Prescribing. 
 advice and information is also offered to patients referred to Social Prescribing; 
benefit checks are undertaken during home visits and support is provided to complete 
forms.  
 a ‘Linkline’ service is also available; this is a telephone support service for lonely older 
people. Volunteers telephone vulnerable people (over 55) each morning to see how 
they are. This provides carers with support as well, knowing that the individual they care 
for has had a reassuring call each morning. 
Patient Case Studies 
Mrs A  
Mrs A is a 93 years old and lives alone. She has a gardener, a lady who does her 
housework, a lady who gives her a shower twice a week, somebody who takes her out 
shopping and a Falls Prevention team, which the re-abling team referred her to, visits.  She 
has various long-term health conditions; rheumatoid arthritis, thyroid, stomach problems, 
macular degeneration (gradual loss of vision), & mobility problems. Her health substantially 
restricts what she can do in terms of household domestic tasks and her general care. She 
doesn’t see her family and friends as often as she would like; a close friend visits fortnightly. 
She enjoys listening to opera and attending the social centre at Age UK.  
Mrs A said she liked the bi-weekly home visits made by the re-abling team. ‘It’s someone 
coming to talk to me and with me and they acknowledge me…because you can sit and stare 
at space and people take no notice whatsoever’. She is also provided practical help, for 
example, to turn on the television, opening tins, and even being assisted to do mild 
exercises. As the team could not re-able Mrs A, her home visits were reduced to one per 
week and she was referred to the befriending service. ‘I feel like I belong to a society’. A 
number of interventions have been made to avoid slips and falls, for example, she was 
bought new slippers and shoes because because her footwear was too big and a 
handyperson was sent out to fix her toilet seat. Mrs A feels more positive than before Age 
UK got involved in her life.  
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Mrs B 
Mrs B is 93 years old and housebound. She has a cleaner, who visits daily and a carer who 
visits every morning, at lunchtime and at bedtime. A mobile library service has also become 
available, which is handy as she enjoys reading.  Mrs B has a number of long-term health 
conditions; painful knees which have to be washed and bandaged by a nurse twice a week. 
She recently had an operation on her hands for Carpal Tunnel Syndrome and when she 
went into hospital two years ago (for six weeks) with a clot on her lungs, they found that she 
also had an enlarged heart and irregular heartbeat. She never goes out unless family 
members can take her. She rarely sees her family and recently lost her close friend, and 
since then she has felt lonely. A befriender through Age UK, part of the social prescribing 
service, has been visiting her once a week. Her befriender has offered to take her out, but 
she isn’t keen, she’d rather stay at home and have company. It’s ‘just somebody to natter to 
for a while’. She felt this relieved some of her loneliness. Through the Social Prescribing 
service , Mrs B is entitled to 10 visits, free of charge, but to continue after this, she has to 
pay a fee of 3 pounds per visit, which Mrs B has recently started doing.  
 
Mrs C 
Mrs C is 63 years old and lives at home with her husband, for whom she is a carer. Her 
daughter helps when she visits once a fortnight. Her friends tend to visit once every two-
three weeks. She has limited hobbies due to her health conditions, which include polio, 
arthritis, and poor mobility. Mrs C struggles to do household jobs. Recently, she saw her GP 
and has visited her district nurse 2-3 times, and she was admitted to Accident and 
Emergency in October. Since Age UK got involved through the social prescribing project, 
she has received considerable support, including Occupational Therapy; access to a mobility 
scooter and confidence building to use it; as well as a carer’s assessment for her husband. 
She thinks ‘more people should know about the service…things have got better since the 
Age UK visits’.   
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Case Study 3: Kimberworth Park Community Partnership 
Organisation 
Kimberworth Park Community Partnership (KPCP) is an umbrella organisation for individuals 
and groups involved in running activities in the Kimberworth Park area. The partnership is 
based at the Chislett Youth & Community Centre through which a range services and 
activities for children and families, younger and older people are developed and delivered. 
The Chislett Centre is an important community resource, providing a low-cost community 
gym and rooms that can be hired for local community events and activities. 
Services provided through Social Prescribing 
Unlike other Social Prescribing services, which receive referrals from a Voluntary and 
Community Sector Advisor (VCSA), KCPCP receive referrals directly from the Integrated 
Case Management Team (ICMT). Following referral the KPCP Project Coordinator makes a 
home visit to carry out an initial assessment following which patients are referred to local 
neighbourhood services, including: the community gym, gardening project, befriending, 
luncheon club, financial inclusion support, massage/pamper sessions, fitness groups, social 
groups, employment advice.  
Patient case studies 
Mrs A 
Mrs A is 75 years old, and lives alone. A cleaner visits twice a week and a gardener once a 
week. She sees one of her sons two/three times a week and another son who lives further 
away, two/three times each year. A close friend used to visit every week, but can’t anymore 
because she is unwell. Mrs A is an avid reader, but can’t pursue other hobbies due to her 
mobility problems. She had a heart attack earlier this year, and she has had a hip 
replacement. Four years ago she suffered a stroke which led to partial paralysis and affected 
her day-to-day life, ‘I can’t do anything that I used to do before’. Her general well-being 
declined. Since accessing activities  through the Social Prescribing service she has started 
to feel a lot better, ‘at least I’m not getting up in the morning and thinking, when’s it time to 
go back to bed. I can get out and keep myself doing something, which is brilliant’. She 
attends an arts and craft session and a creative writing group at the centre each week, which 
she found out about from the KPCP Project Coordinator, and a chair exercise class (not part 
of the SPS). ‘The creative writing gives me a chance to keep me brain going….because if 
I’m in the house all I do is sit and watch telly all day because I can’t stand and do things’. 
Mrs A relies on community transport due to her mobility problems.  
Mrs A’s GP referred her to the social prescribing service and consequently, the KPCP 
Project Coordinator did a home visit, ‘I didn’t want to go anywhere, where all they did was 
play bingo’. She is pleased that her doctor considered an alternative for her, instead of 
medical intervention. She wanted companionship because she was lonely sitting at home 
and needed something to get her out of her depression, for which she was receiving 
medication.  
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Mrs B and Mr C (son of Mrs B) 
Mrs B is 65 years old and has severe arthritis, and mobility problems. Her husband, Mr B, is 
73 years old. He has had multiple strokes. Their son, Mr C, is 28 years old and has 
responsibility for the care of both his parents, which involves, cleaning, shopping etc. A VAR 
Voluntary Community Sector Advisor (VCSA) and the KPCP Project Coordinator visited the 
family at home as a result of GP referral. They did an initial assessment and talked to the 
whole family at the same time, using a household approach to support them. They learned 
that the household only received respite care two afternoons each week for Mr B through 
social services, so they arranged Social Prescribing service sessions for Mr B at the 
Rotherham United Community Sports Trust once a week, and he was referred to the 
Crossroads Care sit-in service, giving Mrs B time to get out and about. Mrs B has been to a 
couple of Social Prescribing service pampering, and arts and crafts sessions.  
In addition, the Project Coordinator got Mr C involved in volunteering, supporting an older 
peoples indoor bowling group, three times a week to get him out of the house, ‘I’ve enjoyed 
it, just getting out the house for a few hours, sommat to do’. It has been difficult for Mr C to 
live with his father’s dementia and his frustration, which he has sometimes taken out on his 
family, consequently, affecting Mr C’s confidence. The Project Coordinator involved Mr C in 
volunteering to ‘widen his access to other opportunities’.  Mrs B feels better emotionally 
because she ‘has something to look forward to’. 
 
Mrs D 
Mrs D is 86 years old and is hard-of-hearing. She lives alone in sheltered accommodation for 
old people, which is monitored by a warden. Her daughter visits once every three weeks and 
her son visits fortnightly. All of her friends have passed away. She feels lonely, particularly 
during the dark, colder months. She enjoyed reading, but her sight is so poor that she cannot 
do this anymore, so she spends most of her time watching television. Mrs D has heart 
problems, and is on a lot of medication for various long-term conditions. She struggles with 
her mobility, but makes an effort to walk to her local shop on most days. She can only do 
minimal housework, so a cleaner visits once every fortnight.  
Following an initial assessment Mrs D decided to give the arts and crafts sessions a try. She 
is dependent on community transport to get to the centre. Over time, she has got to know a 
few of her group, ‘I feel a bit better…when I come here, I’m alright'. She has a purpose and 
something to talk to her family about when they visit. The Social Prescribing service hasn’t 
had any impact on her use of health services, but without the service she says she would be, 
‘lost, I wouldn’t know what to do’. 
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Mr E  
Mr E is 54 years old and lives at home with his wife and son. He suffered a severe stroke 
three years ago, which affected his mobility and his speech. Before this, he had an active 
lifestyle; he enjoyed cricket and football but couldn’t play anymore. His wife contacted the 
Project Coordinator for support to get him active and involved. Within a week of his 
assessment Mr E had started going to a gym session and was provided with transport to get 
to the centre. 
He attends the gym one day and creative writing on the other. He also goes out for pub 
meals. As a result of receiving support from the Social Prescribing service, Mr E has become 
more independent and positive, ‘I was on my own, I was totally on my own’. Since going to 
Chislett, his mobility has improved. Before Chislett, he felt very low, but now he is getting 
better. ‘Each day I’m getting better and better…before I could hardly walk’. He was told that 
his health would never improve, but the Social Prescribing service has made a huge 
difference, ‘I’m feeling very positive, each day I get up and I just can’t believe how much I’ve 
come on’. 
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Case Study 4: Sense 
Organisation 
Sense is a national charity which works with people who are deaf and/or blind, and or 
experience other sensory impairments, providing support and services to assist people who 
are deaf or blind to live fulfilling and independent lives. They typically receive referrals from 
social services and health professionals, as well as the Social Prescribing service.  A diverse 
range of activities and services are provided including: daily living skills, opportunities for 
voluntary work, arts and crafts, swimming, gym use, shopping, and eating out.  The resource 
centre has a sensory room, computers and sound beam, and a ball pool. 
Services provided through Social Prescribing 
Funding from the Social Prescribing Pilot provides sensory art and craft sessions for 8 to 10 
people and include activities such as textiles, pottery, music, and storytelling. The Service 
Manager and facilitator provide support with sensory impairment to ensure that people are 
able to socially interact, that the environment is right and that the activities are accessible. 
The initial assessment of patients is now carried out by Sense staff instead of VCSAs, which 
allows patient needs to be identified immediately and avoids duplication. Although the 
service is similar to other services that Sense provides, Social Prescribing activities are 
generally more three dimensional rather than two dimensional to meet the specific needs of 
the beneficiaries. 
Patient case studies 
Mrs A 
Mrs A is 81 years old and lives alone, managing without a carer, in a warden assisted flat. 
She has a cleaner every Monday afternoon, who provides some company.  Her eyesight is 
impaired and she rarely sees family or friends; she spends a lot of time alone. ‘I do like 
company, but there’s nobody to be company with…I do get lonely…because I can't see telly 
properly’. Although a neighbour helps with her shopping, they don’t socialise. She frequently 
has falls at home, which she doesn't report to her doctors; the last fall being three months 
ago. She found out about the Social Prescribing Service through her GP, ‘I was very 
depressed for 18 months and I went off my food, I just wanted to lay in bed, I just wanted to 
pull the plug out….I just wanted to lay and die. I had no interest in anything’. 
The Voluntary and Community Sector Advisor (VCSA) told Mrs A about the various activities 
available through the Social Prescribing service, some of which she took up, with few 
expectations initially.  Activities included arts and crafts at Sense, weekly exercise classes at 
The Titans and at Rotherham United.  Transport was provided by Rotherham Community 
Transport.  She also had a befriender, but decided not to continue with this service.  She 
finds the activities at Sense enjoyable, and getting involved in Social Prescribing service 
activities has got her out of her depression, ‘coming to these groups, I’ve got a social life and 
I feel better’.  Other members of the sense group have been helpful, for example, buying Mrs 
A fruit when her daughter hasn’t been able to take her shopping. 
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Mrs B 
Mrs B is 39, and lives at home with her son. Her mother and son are her main carers. She 
suffered a major stroke at the age of 31, leading to a loss of feeling down the right side of 
her body and mobility problems, a speech impediment, memory loss, and visual impairment.  
She also has asthma, severe anxiety and depression, which have led to a fear of going out 
and panic attacks.  Occupational Therapists visit routinely and Rothercare provide support in 
relation to falls and she visits the Rotherham Intermediate Care (Council) once a week to 
improve confidence and balance.  Mrs B sees her GP once a month and during the last six 
months she has been in hospital twice; the first time after having an asthma attack, and 
again when she had a fall and broke her wrist.  Mrs B's GP told her about the Social 
Prescribing service and put her in contact with a VCSA, who did an initial assessment at 
home.  The pilot nature of the scheme was explained to Mrs B, which she understood. 
Since attending the first session at Sense, Mrs B has received advice and information about 
specific problems, as well as help finding practical solutions in relation to her disabilities, for 
example, opening tinned food.  She pays £3.50 for increased sessional hours, including 
lunch. The group provides an opportunity to meet people and interact, and is seen as a 
lifeline, ‘If it wasn’t for the group, I might not be here now because I’d been that down and 
depressed…just getting out of the house has helped me with the fear, anxiety…talking to 
people lifts your mood and forget about problems at home'. From taking tentative steps, she 
has become a proactive member of the group and has produced a Facebook account for the 
group to display their artwork.  Her mother and son notice an improvement in mood during 
the week, but this dips at the weekend when there is less to do, and the session at Sense 
(on Wednesdays) seems some time away.  Whilst Mrs B's many health problems will persist, 
attending sessions at Sense allows her to put her health problems aside for a couple of 
hours in a mutually supportive environment. 
 
Mrs C 
Mrs C is 63, and lives at home with her husband.  They are both provided care every 
morning and night.  She has had three strokes, and has chronic asthma and a blood 
disorder.  The strokes have led to mobility problems, which cause her considerable 
frustration.  Family members visit once a fortnight.  She likes to read, and enjoyed driving but 
can't do this anymore. Many aspects of her life involve relying on others, for example, getting 
dressed, shopping etc. As a result, she sees no purpose to her life, ‘your life is not your 
own’.   
Since her GP referred her to the Social Prescribing service, she has attended sessions at 
Sense for 15 weeks, using community transport.  Initially, she found it intimidating and it took 
some time to adjust to the group because Mrs C finds it difficult to talk to new people, but 
over time she has become more confident, ‘we talk about various things, about what we’re 
doing, and how you’re feeling’.  She didn’t expect to get anything out of the service but has 
realised that she doesn’t feel as isolated and was 'just looking at four walls without the 
service'. Importantly, she noted, ‘while you’re here you don’t think about your health 
conditions, you just get on with it’.  Any opportunities to attend more often would be taken 
up. She has socialised with another beneficiary outside of Sense sessions a couple of times 
and does reiki with another provider.  At Sense there is something to look forward to each 
week, ‘It makes us feel worthy instead of worthless, and less depressed'. 
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Case Study 5: Tassibee 
Organisation 
Tassibee is a registered charity, established in 1993 to meet the educational, training and 
health and welfare needs of Pakistani women in Rotherham. Currently, the activities run by 
Tassibee include: a Carers' Project; a Ramadhan Project; a drop-in service; a prayer session 
every Friday; classes in Arabic, English, and positive parenting; events to raise awareness; 
an arts project; work with schools; and signposting families in crisis to support services. 
Services provided through Social Prescribing 
A one-to-one Peer Advocacy and enabling service for BME women is provided as part of the 
Social Prescribing service. The service is delivered in patients' homes, at other venues or 
the Tassibee Centre if required, and includes: one-to-one emotional/ practical support in the 
home and enabling patients to access community activities. Peer advocates provide support 
to enable access to health services and social care packages. 
Patient case studies 
Mrs A 
Mrs A is 56 years old and lives at home with her daughter, daughter-in-law and two 
grandchildren. She is able enough to take care of herself, but has increasingly experienced 
joint pain from arthritis over the last two-three years. She was diagnosed with diabetes (over 
ten years ago), and she suffers from high blood pressure, high cholesterol, and has a visual 
impairment. Mrs A was referred to the Social Prescribing service by her GP.  
Mrs A has social connections with local women and gets out of her home. She is involved in 
the rearing of her grandchildren, so rarely has time to feel alone during the day, but she feels 
very down at night when the arthritic pain is at its worst and during this time she begins to 
think about her other problems (not divulged). She cannot sleep at all. She struggles to 
speak English and is illiterate in her mother tongue. Her benefits were stopped two months 
ago and she accessed Tassibee for assistance. An advocate at Tassibee helped her fill in 
benefit forms and to apply for a free bus pass. She is pleased with the support she has 
received, ‘I was completely stuck, I didn’t know who to go to and what to do’. She feels a 
little better within herself; the advocate checks on her through regular phone calls, and asks 
whether she wants to go out.  
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Mrs B & Mrs C 
Mrs B is 77 years old and is in the middle stages of dementia, which she has had for 
approximately five years. As a result of her condition, Mrs B can be abusive and difficult. She 
also has arthritis and diabetes, but is still fairly mobile. Mrs B and her family were referred to 
the Social Prescribing by their GP, who referred them on to Tassibee. Mrs C is 43 years old 
and the daughter-in-law of Mrs B and her full-time carer. Although it is a large household (10 
members of various ages), and they have managed, recently some family member’s 
commitments have grown, and the burden of care has increasingly fallen on Mrs C, who 
does everything from bathing to changing her mother-in-law.  
The family knew about Tassibee, but didn’t know they were involved in delivering patient and 
carer support. The respite Tassibee provides allows the family to, ‘plan forward, before we 
couldn’t….It’s given us a bit of social time as well’. Mrs B is taken out once a week, 
according to her preference, and recently, her family has applied for direct payments to 
increase Mrs B’s visits out to twice a week. She said, ‘they (Tassibee) pick me up, drop me 
off, it’s a very good facility’. The burden on her daughter-in-law has been alleviated to some 
extent, ‘some days you just need mentally to distance yourselves’.   
 
Mrs D 
Mrs D is 72 years old and lives with her son and his family. The household consists of seven 
members, including Mrs D’s husband who has various health problems. Her husband 
causes disturbance when he is in pain and this prevents Mrs D from having peace and 
getting sleep. She is severely depressed and feels alone; her family offer little reassurance 
and she doesn’t have any friends. Her daughter-in-law is her carer, but she is often busy 
meeting her household’s needs. Previously, Mrs D had a very busy, successful career, but 
had to give it up when her husband had a heart attack. She still enjoys reading, and writing 
poetry. Mrs D has arthritis, a visual impairment and various other health problems. She was 
referred to Tassibee by her GP, and as a result, the VAR Advisor did a home visit to discuss 
her needs. 
A Tassibee Advocate takes her out once a week (for three hours); she has been shopping, 
to the bank, eating out, and for a walk in the park. ‘Getting out has made me feel very good’. 
She felt like she was locked in her home and the Social Prescribing service has supported 
her to get out. She went to an exercise class and Mrs D feels she benefited from it 
immensely, for example, her shoulder pain has gone and she has started walking with ease, 
noting ‘a big difference’. She has regained some independence, and feels better physically 
and emotionally because she has something to look forward to. Without the Social 
Prescribing service, she would withdraw within herself and become isolated again.    
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Appendix 2: Overview of funded social 
prescribing services in Rotherham 
Service provider Type of service or activity Summary of service or activity 
Active Independence Peer advocacy with volunteering opportunities 
Advocacy and support service for people who need help to access social care 
packages 
Active Regen 
Group activity/mobility sessions 
(1) Strength and balance activities, (2) Computer gaming activities, (3) Walking 
for beginners, (4) Boccia 
Senior peer mentoring - 'Active Friends' buddy scheme 
(1) Senior Peer Mentor training programmes, (2) Senior Fitness Testing 
sessions, (3) Moving More Often training course 
Age UK 
Advice and Information Home visits providing welfare benefits advice 
Reablement service Home based 1 to 1 practical and emotional support  
Befriending service 1 to 1 befriending service - in the home or community 
Alzheimer's Society 
Dementia Support Worker Service 
Signposting, advice and support, including practical support to attend dementia 
cafes and other groups as appropriate 
Dementia Volunteer Befriending service 
Volunteer led befriending service providing companionship and emotional 
support, and support to participate in leisure and social activities and other 
regular activities such as shopping 
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Service provider Type of service or activity Summary of service or activity 
British Red Cross  Volunteer-led befriending and enabling service 
Goal orientated volunteer befriending support to enable independence in the 
home and encourage community participation 
Crossroads Care 
Flexible carer respite service 
Carer assessment; information and signposting; flexible respite; complementary 
therapies; carer training; peer support group 
Sitting service Sitting service to enable carers to attend Caring With Confidence course 
Elmet 
Archaeological 
Services 
Drop-in reminiscence group 
Facilitated reminiscence session: memory boxes, music, artefacts, and social 
interaction. 
High Street Centre 
(Rawmarsh) 
Activities Co-ordinator 
Activities Co-ordinator introduces patients to activities in High Street Centre; 
volunteer befrienders accompany patients to activities of their choice;  new 
activities will be set up in the Centre to meet patient needs 
Kimberworth Park 
Community 
Partnership 
Home visits and referral to community activities 
SPS refers direct to KPCP Project Co-ordinator for home visit and referral to local 
neighbourhood services: community gym, gardening project, financial inclusion 
support, massage/pamper sessions, fitness groups, social groups, employment 
advice 
Lost Chord  Music sessions for people with dementia 
Professional musicians providing music sessions for people with dementia in 
Alzheimer's Society Memory Cafes 
Montgomery Hall 
(Wath) 
Activity Co-ordinator at Montgomery Hall 
Activities Co-ordinator introduces patients to activities in Montgomery Hall and 
the wider community. New activities will be developed meet needs of patients. 
Volunteer befrienders provide transport 
Rotherham 
Community 
Transport 
Volunteer driver scheme and improved booking and 
scheduling service 
Launch of volunteer driver training programme. Booking and scheduling will 
become responsive to individual needs.  SPS referrals to RCT to be logged on a 
new system 
Rotherham Ethnic 
Social Care 
Organisation  
Two group activity programmes for BME carers  (1) Health & well-being sessions, (2) Cultural activities and away days.  
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Service provider Type of service or activity Summary of service or activity 
Rotherham United 
Community Sports 
Trust 
Home Exercise visits Weekly home visits to help improve mobility/flexibility through gentle exercise.   
New York Stadium activity sessions 
Weekly activity sessions including at the New York Stadium:  gentle exercise, 
healthy eating advice, reminiscence/life stories, games, creative writing, lunch.   
Community based activity sessions 
Similar sessions to those held at the New York Stadium but delivered in 
community venues in Wickersley and Dinnington 
Royal Voluntary 
Service 
Volunteer-led good neighbours befriending and enabling 
scheme 
Befriending in the home, escorting to appointments, shopping on behalf of or 
with, linking people to community activities, transporting patients.  
Satori Counselling 
One-to-one therapeutic counselling and additional group 
work sessions 
1 to 1 counselling at RAIN building or in patient's home if appropriate.  Separate 
group sessions at Wickersley Library 
Self Management 
UK  
Caring with Confidence course  7-week Caring With Confidence course delivered in a community venue  
Sense  Sensory art & craft group sessions  Sessions involve textiles, pottery, music, storytelling 
South Yorkshire 
Centre for Inclusive 
Living 
One to one Support Worker personal service 
1 to1 Support Worker service to enable patients to live a more independent life: 
home visits and accompanying patients to appointments, shopping trips, social 
events and activities etc.  Also help with benefits and accessing other statutory 
services 
Facilitated 'afternoon tea' sessions 
'Afternoon tea' sessions in community venues facilitated by the Project Co-
ordinator 
Surehealth  Community based Tai Chi classes Weekly Tai Chi classes 
Tassibee 
One to one Peer Advocacy and enabling service for 
BME women 
1 to 1 emotional/practical support in the home and enabling patients to access 
community activities.  Delivered by peer advocates with advocacy support to 
enable access to health services and social care packages.  
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Service provider Type of service or activity Summary of service or activity 
Titans Community 
Foundation 
Home visits from Rotherham Titans first team players  
Four 2-hour weekly visits per patient - providing companionship and light 
exercise if required. Patients are encouraged to attend group sessions at Clifton 
Lane 
Group activities at Clifton Lane Sports Ground 
Weekly group activities at Clifton Lane Sports Ground including light exercise, 
social activities 
Unity Centre  Group activity sessions for Asian men  
Group support for Asian men aged 50+ from BME communities, particularly 
Yemeni and Pakistani.   Includes life stories/memories, exercise sessions, 
information sessions, end of project trip 
Universal Embrace Complimentary Therapy and social group sessions Complementary therapy and social group sessions   
 
